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Abstract 
Early intervention approaches have rarely been 
implemented for the prevention of ADHD. In this paper we 
explore whether such an approach may represent an 
important new direction for therapeutic innovation. We 
propose that such an approach is most likely to be of 
value when grounded in and informed by bio-psycho-social 
developmental models of the dynamic, complex and 
heterogeneous nature of the condition. First, we set-out 
a rationale for early intervention grounded in the 
science of ADHD viewed through developmental models. 
Second, we re-examine the concept of disorder-onset from 
the perspective of developmental trajectories and 
phenotypes. Third, we examine potential causal pathways 
to ADHD with regard to originating risk, 
pathophysiological mediators, environmental moderators 
and developmental continuities. Finally we explore the 
potential value of strategies for identifying young 
children at risk for ADHD, and implementing 
interventions in ways that can target these underlying 
pathogenic processes. The utility of such an approach 
represents an important area for future research but 
still requires ‘proof of concept’. Therefore prior to 
widespread clinical implementation, far greater 
knowledge is required of (i) developmental pathways into 
ADHD, (ii) the value of identifying neuropsychological 
mediators of these pathways, and (iii) the extent to 
which targeting mediating mechanisms will improve 
treatment outcomes for children with ADHD.  
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Attention Deficit/Hyperactivity Disorder (ADHD) is a 
chronic debilitating condition associated with 
significant costs to patients, families and society, and 
burden to social and health care services (Taylor & 
Sonuga-Barke, 2008). Although current treatments can 
often be implemented effectively (Banaschewski et al., 
2006), there is still considerable unmet clinical need. 
Clinical benefits from pharmacological interventions 
often dissipate over time (Jensen et al., 1999) and 
long-term effects remain uncertain (Jensen et al., 2007; 
Molina et al., 2009). Compliance with stimulant 
medication is also quite poor (Corkum, Rimer, & 
Schachar, 1999; Perwien, Hall, Swensen, & Swindle, 2004; 
Sanchez, Crismon, Barner, Bettinger, & Wilson, 2005): 
Fewer than 10% of children with ADHD persist with long-
term medication treatment (Weiss, Gadow, & Wasdell, 
2006). There are also side-effects; especially affecting 
sleep (Graham & Coghill, 2008), appetite (Karabekiroglu, 
Yazgan, & Dedeoglu, 2008) and growth (Swanson et al., 
2007a). To complicate matters further, parents and 
clinicians often have reservations about using 
medication to control behaviour, especially in very 
young children (Berger, Dor, Nevo, & Goldzweig, 2008). 
Available behaviour modification strategies, are more 
complex and time consuming to implement, and typically 
less efficacious for core symptoms of ADHD (Antshel & 
Barkley, 2008), although valuable when targeted at 
complications of ADHD such as oppositional behaviour 
(Jones, Daley, Hutchings, Bywater, & Eames, 2008). 
Generalisation and maintenance of effects have rarely 
been shown for such treatments (McGoey, Eckert, & Paul, 
2002; Barkley et al., 2000). Similar to medication, 
gains rarely persist long after active treatment is 
terminated (Chronis et al. 2004; Pelham & Fabiano, 
2008).   
Thus there remains a need for the development of 
new therapeutic approaches for ADHD that can produce 
generalised long-lasting change.  In this paper we 
examine a potential role for early intervention in 
therapeutic innovation (Tamm et al., 2005). Our goal in 
this paper is not to provide a ‘prescription for early 
intervention’ in ADHD but rather to make a case for this 
as a rational approach to therapeutic innovation. In the 
process we review and synthesize diverse literatures 
from both within and outside the narrowly defined ADHD 
domain, and then propose a general framework to guide 
such an enterprise as well as some practical examples of 
instantiation. Initially we set-out the scientific and 
clinical case for early intervention as a rational basis 
for treatment development in ADHD. Next we introduce the 
concept of early developmental phenotypes. We then 
describe how studying developmental phenotypes and their 
specific causes and mediating processes can help us 
identify potential targets for early intervention. This 
builds on our taxonomy of putative developmental 
pathways to account for the potential heterogeneity of 
the condition. Finally we explore possible ways to 
identify early risk for later ADHD and assess the value 
of different approaches to early intervention.  
A: THE EARLY INTERVENTION PROPOSITION IN ADHD – A 
TRANSLATIONAL FRAMEWORK FOR CONCEPTUALIZING THERAPEUTIC 
INNOVATION? 
In this paper we explore the hypothesis that early 
intervention for ADHD which targets underlying causal 
pathways (Nigg, 2006) can reduce the likelihood of 
disorder emerging, limit its persistence, and cut its 
associated long-term burden (Tamm et al., 2005). We 
propose that; (i) rational treatment development 
involves identifying/targeting the causes of a 
condition; (ii) causes of ADHD should be cast, not as 
static/fixed neuro-psycho-biologic deficits, but rather 
in terms of underlying developmental processes (Taylor, 
1999; Schmidt & Peterman, 2008); and (iii) targeting 
these processes early can bring about fundamental 
alterations in the pathogenesis of ADHD, and thus 
prevent the emergence, or moderate the course of, the 
disorder. Based on this logic early intervention for 
ADHD should, in principle, have preventative potential. 
Below we set out the logic behind this vision in more 
detail and highlight many of the very considerable 
barriers to bringing it to fruition.  
 I: Toward therapeutic innovation in ADHD: Is there a 
need to embrace translational science?  
Therapeutic innovation can emerge from knowledge of the 
causes of the disorder which can be used to target 
treatments. The search for these targets is one element 
of translational science (Curry, 2008). The development 
of existing therapeutic approaches to ADHD has rarely 
been directly informed by knowledge of its psycho-
pathophysiology (Beauchaine, Neuhaus, Brenner, & Gatke-
Kopp, 2008). Rather, new treatments have emerged as a 
result of clinical insight and/or trial and error, or 
have been borrowed from other therapeutic domains.  
As our knowledge-base relating to the causes of 
ADHD grows (Nigg, 2006) it becomes more feasible to 
ground the search for new treatments in translational 
science than it was in the past (Bellgrove, O’Connell, & 
Vance, 2008). Nevertheless, there have been few attempts 
to systematically implement such an approach in relation 
to ADHD (see Kerns, Eso, & Thomson, 1999; Klingberg et 
al. 2005; Shalev, Tsal, & Mevorach, 2007). Innovations 
in drug treatments have been based primarily on an 
improved understanding of the psycho-pharmacology of 
existing treatments (e.g., the development of extended 
release formulations of methylphenidate - Volkow & 
Swanson, 2003; Swanson et al., 2003). In general, non-
pharmacological approaches, typically adapted from 
generic models of intervention ‘borrowed’ from other 
clinical domains (Sonuga-Barke, Thompson, Abikoff, 
Klein, & Brotman, 2006),  have rarely been developed 
with the goal of treating the ‘causes’ of ADHD. 
Relatedly, innovative use of attention training 
(Sohlberg & Mateer, 2001) and neurofeedback (Heinrich, 
Gevensleben, & Strehl, 2007) build on generic accounts 
of attention rather than on ADHD models (Lubar, 1997). 
Where ADHD models have guided therapeutic innovation, 
(e.g., working memory training; Klingberg et al., 2005) 
efficacy remains to be clearly established.  
The failure of basic research into the 
underpinnings of ADHD to influence treatment development 
could have two causes. First, we may not have adequate 
models of the causes of ADHD. A second possibility is 
that though such models exist they cannot be 
implemented.   
II: The bio-medical model is a barrier to translational 
science in ADHD. 
More than three decades of intense research into ‘the 
causes’ of ADHD has yielded a vast database relating 
ADHD to a range of genetic and environmental risk 
factors (Taylor & Sonuga-Barke, 2008) and neuro-
psychological and –biological alterations (Willcutt, 
Sonuga-Barke, Nigg, & Sergeant, 2008). Nevertheless, a 
complete understanding of the condition remains a 
distant goal.  
Data suggest that; (i) ADHD has a complex causal 
structure with different facets interacting in additive, 
synergistic and possibly antagonistic ways (Nigg, 2006); 
(ii) initiating neuro-biological causes are remote from 
the disorder and operate as non-deterministic risk 
factors that are mediated and moderated by multiple 
factors (Taylor, 1999); (iii) effects of any one factor 
or set of related/interacting factors are likely to be 
small and operate in different ways in different 
children (Taylor & Sonuga-Barke, 2008; Swanson et al., 
2007b). Such aetiological heterogeneity is increasingly 
apparent in the literature and suggests that different 
sub-groups of patients may ‘follow’ different pathways 
(Nigg, 2006). It is also evident in everyday clinical 
reality (Taylor et al., 2004) where treatments should be 
tailored to meet specific needs of individual patients 
(Leslie, Stallone, Weckerly, McDaniel, & Monn, 2006).; 
(iv) ADHD is a lifespan developmental disorder; its 
roots can be traced back to the early stages of life and 
its clinical manifestations often persist into 
adolescence and adulthood (Vaughan, Wetzel, & 
Kratochvil, 2008; Schmidt & Peterman, 2008).  
The challenges presented by this mix of factors is 
exacerbated by the fact that the science of ADHD remains 
(at least implicitly) wedded to the traditional bio-
medical model, which does not provide a framework for 
modelling complex and developing systems (Sonuga-Barke, 
1998). The search for core fixed deficits, which this 
model promotes, is deficient as a basis for ADHD 
research (Sonuga-Barke & Castellanos, 2005). It cannot 
account for the way causal processes seem to interact in 
dynamic and non-linear ways producing diverse patterns 
of persistence and remission found in ADHD (Halperin, 
Trampush, Miller, Marks, & Newcorn, 2008) and leading to 
the emergence of co-morbidities (Mannuzza, Klein, 
Abikoff, & Moulton, 2004). It takes us no further in 
understanding how different groups of individuals can 
display markedly different patterns of brain alterations 
and neuro-cognitive deficits and yet all still have ADHD 
(Sonuga-Barke, 2005). Singh (2008) recently identified 
the bio-psycho-social model, in which ADHD is seen as 
caused by the interplay of genetic and environmental 
influences that occurs over development in underlying 
neuro-biologic systems as potentially the most useful 
framework for understanding ADHD.  
III: Modelling complexity and heterogeneity in ADHD by 
studying developmental processes.  
The bio-psycho-social model (Engel, 1977) provides a 
conceptual basis for research into the causes of 
psychiatric conditions such as ADHD (Fava & Sonino, 
2008). It views mental health problems as emerging out 
of developmental pathways from risk to disorder, with 
the course determined by the interplay between genetic 
and environmental risk factors manifest in alterations 
to underlying neuro-biological processes. Crucially it 
embodies a dynamic, rather than a static/fixed, 
conception of cause. From this perspective, ADHD cannot 
be understood simply in terms of structural and 
functional brain deficits (or their specific 
aetiological precursors). Rather it views ADHD in terms 
of the processes of alteration, and their associated 
determinants, that affect brain structure and function 
during development and that may be manifest as such 
deficits.  
This developmental psychopathology perspective, 
well-established for other conditions (Cicchetti & Toth, 
2009), was first applied systematically to ADHD by 
Taylor (1999) and is increasingly embraced (Halperin & 
Schulz, 2006; Kieling, Goncalves, Tannock, & 
Castellanos, 2008; Sagvolden, Johansen, Aase, & Russell, 
2005; Nigg, 2006; Sonuga-Barke, 2003; 2005; Swanson et 
al., 2007b). A recent synthesis of elements from these 
accounts (Sonuga-Barke, 2009) develops several important 
themes. First, the existence of a continuum of neuro-
biological risk in the population, neither exclusively 
genetic nor environmental in origin, but rather the 
product of an interplay between numerous individual risk 
factors (Thapar, Langley, Asherson, & Gill, 2007). 
Second, psychopathophysiological mechanisms altered in 
ADHD mediate developmental risk-disorder pathway 
(Sonuga-Barke, 2005). Third, the conditional nature of 
effects are complicated by both equi-finality (different 
originating risks leading to the same clinical outcome) 
and multi-finality (the same pattern of risk factors 
leading to different outcomes; Cicchetti & Blender, 
2006). That is, outcomes are determined by the extent to 
which originating risk is moderated by later factors to 
alter the trajectory of development. Moderation may be 
protective (i.e., resilience; Rutter et al., 2007) – 
where for instance an at-risk child has a good outcome 
because of some secondary endogenous or exogenous 
resilience mechanism (e.g., personality, intelligence, 
supportive/constructive parenting). It could also have a 
negative character whereby children with few apparent 
risk factors go onto develop ADHD. Understanding these 
moderating influences is assumed to be vital to 
predicting the emergence of disorder, its persistence 
and offset, and the development of other outcomes 
associated with the disorder. Developmental 
heterogeneity is at the heart of this conception with 
the goal of identifying the diversity of causal 
processes paramount.  
IV:  Shifting the focus to early intervention and 
prevention.  
A developmental psychopathology perspective shifts the 
search for treatment targets from fixed core deficits to 
multiple developmental processes that mediate the 
disorder. This developmental conception of ‘cause’, 
distinguishes causal processes from developmental 
outcomes (i.e., the disorder), and gives particular 
priority to precursor states and processes as 
intervention targets. As such, intervening early should 
be more successful than waiting until outcomes are 
established and then trying to reverse the pathogenic 
process.  
Nevertheless, despite the growing adoption of a 
developmental perspective on ADHD and the successful 
application of the principles of prevention science to 
other disorder (see Rapee, 2008 for a discussion), early 
intervention has been less frequently used for ADHD than 
other disorders (Shaw, Dishion, Supplee, Gardner, & 
Arnds, 2006). This reluctance may to a certain extent be 
shaped by a deterministic notion of cause that leads to 
the idea that ADHD is not amenable to the moderating 
effects of environmental and/or biological 
manipulations. Recent evidence regarding brain 
plasticity in developmental disorders may be seen to 
contradict this position (Dawson, 2008), and the 
conditional nature of risk-disorder pathways should 
temper such deterministic pessimism.  
In keeping with this we postulate that early 
intervention that targets these processes could alter 
developmental trajectories and improve outcomes over the 
long term (Miklowitz & Cicchetti, 2006). However, the 
veracity of this hypothesis remains an open empirical 
question; there is little or no evidence to date to 
support it. It is possible that early intervention may 
in the end not be an effective strategy in the case of 
ADHD, in terms of its ability to fundamentally redirect 
developmental pathways, and we may be over-estimating 
the degree to which developmental pathways can be 
actively mediated and moderated. Environmental 
correlates and/or neuro-psychological alterations may 
simply be passive markers of pathways rather than 
actively determining their trajectory. We may also be 
overestimating the extent to which environmental 
experiences influence underlying neuro-biological 
processes in ADHD, despite evidence for neural 
plasticity in the developing brain in response to 
environmental manipulations more generally (Neville, 
2006; Luciana, 2003; but see Rapoport & Gogtay, 2008). 
Indeed, in general the impact of environmental factors 
on neuro-biological outcomes is thought to be 
constrained by the influence of stabilising genetic 
processes such as canalization (Hernandez-Lloreda & 
Colmenares, 2005). Even assuming that risk-disorder 
pathways in ADHD are amenable to influence, what is the 
case for intervening early in development? First, brain 
plasticity appears greatest during early phases of 
development and therefore more susceptible to the 
influence of environmental experience (for good or for 
bad; Rueda, Rothbart, McCandliss, Saccomanno, & Posner, 
2005; Vuksic, Rados, & Kostovic, 2008; Bischof, 2007) 
(but see canalization above). Second, early intervention 
can occur before strong behavioural habits are formed in 
the child exacerbating patterns of impairment. Third, 
early intervention may increase receptiveness of parents 
and families before negative attitudes that often 
accompany ADHD have hardened, making family-based 
interventions difficult. Fourth, it can operate before 
the disorder has become complicated by the experience of 
school failure and associated low self esteem.  
A key issue when implementing an early or 
preventive intervention for ADHD is which children get 
targeted. If the threshold is set too high, many ‘at-
risk’ children will be missed. If set too low, many 
children will receive unnecessary treatment. Balancing 
the relative benefits and costs of missing some “at-
risk” children versus unnecessarily indentifying and 
treating children rests largely upon the “invasiveness” 
of the intervention, its cost, and its potential 
delivery system. If the intervention is “invasive” 
(e.g., medication) or extremely costly (e.g., intensive 
individualized treatment), only those with clear 
evidence of elevated risk will likely participate, 
leaving many children who go on to develop ADHD without 
early intervention. Notwithstanding these factors, the 
early intervention approach to ADHD treatment still 
requires proof of concept; the hypothesis remains 
largely untested. Our expectation is that prevention 
approaches used for related disorders such as conduct 
disorder are likely to be unsuccessful because they do 
not target the underlying causal processes of ADHD. We 
believe that for ADHD, the identification of moderators 
of neurobiological processes may be an essential 
precursor to early intervention.  
 
B: CONSIDERATIONS REGARDING THE CONCEPT OF DISORDER-
ONSET FROM A DEVELOPMENTAL PERSPECTIVE.  
From an early intervention perspective, a key outcome of 
interest is the onset of the disorder. However, if we 
define disorder onset simply as the transition from no 
ADHD to ADHD on the assumption that there are clear 
boundaries we come up against a number of problems.   
I: Despite the practical value of categorical diagnosis, 
ADHD is more accurately characterised as a dimension.  
 A categorical diagnosis of ADHD with clear boundaries 
between the presence and absence of the syndrome 
facilitates clinical decision making (Sonuga-Barke, 
1998). However, clinical pragmatics and scientific 
reality diverge because an underlying causal 
discontinuity between normality and the disorder state 
is very rare: Mental disorder syndromes are seldom 
present in an all-or-nothing way (see Helzer, Kraemer & 
Krueger, 2006). From a bio-psycho-social perspective, 
where multiple risk factors operate together to create a 
spectrum of disease liability, syndrome boundaries 
represent differences in degree rather than kind. While 
there are good conceptual reasons to think of ADHD in 
this way there is also empirical evidence to back-up 
this claim (Polderman et al., 2007; Lahey et al., 2008).  
Taxonomic studies of ADHD provide unanimous support for 
the notion of ADHD as a pole of a continuum distributed 
throughout the population, rather than a qualitatively 
discrete category (Haslam et al., 2006; Frazier, 
Youngstrom, & Naugle, 2007). Furthermore there is no 
difference in patterns of heritability in the extreme of 
the distribution (Gjone, Stevenson, & Sundet, 1996).  
The developmental corollary of the continuum 
conceptualisation of ADHD is that syndrome onset 
represents a transition of degree rather than of kind. 
As with diagnostic thresholds these developmental 
thresholds are inevitably arbitrary to some degree and 
rest on general cultural norms about behaviour and 
development (Timimi & Taylor, 2004; Leung et al., 1996) 
filtered through the expectations of individuals 
applying these standards (e.g., parents, patients, 
teachers, clinicians; Maniadaki, Sonuga-Barke, Kakouros, 
& Karaba, 2007; Sonuga-Barke, Minocha, Taylor, & 
Sandberg,, 1993).  
II: ADHD expression fluctuates during development.  
There is also within-individual variation regarding 
the extent to which diagnostic criteria for the disorder 
are fulfilled at any given time (von Stauffenberg & 
Campbell, 2007). The categorical approach is deficient 
in capturing this dynamic nature of symptom expression 
(Lahey, Pelham, Loney, Lee, & Willcutt, 2005). Symptom 
levels and patterns fluctuate from day-to-day and year-
to-year. Individuals around the diagnostic boundaries 
may meet criteria at one time but not at a second time, 
while at a third time they may once again fulfil 
criteria. For individuals at the diagnostic margins this 
presents a serious challenge to current diagnostic 
approaches – should we say they have a disorder at time 
1, not at time 2 and then again at time 3? Further, it 
is almost impossible to determine whether fluctuations 
represent real changes in behaviour or varying standards 
imposed by those evaluating the child’s behaviour (e.g., 
different teachers). 
We suggest redefining and broadening the concept of 
disorder-onset by moving from a static clinical 
phenotype to a developmental one incorporating the 
notion of syndrome trajectory (Sonuga-Barke, 2009). 
Through this we attempt to capture ‘growth’ by depicting 
patterns of symptom increase, persistence, diminution 
and more general fluctuation across time. This will 
allow us to draw potentially important distinctions 
between ‘early emerging’ and ‘late emerging’ and 
‘persisting’ and ‘non-persisting’ variations (Sonuga-
Barke, Auerbach, Campbell, Daley, & Thompson, 2005). The 
degree to which diagnostic criteria are met at any-one 
time will be placed in the context of a developmental 
trajectory, therefore providing the phenotypic anchor to 
characterise causal processes.  
III: The ‘onset’ of the syndrome may not correspond to 
the ‘onset’ of impairment.  
The third complication in defining disorder-onset as the 
developmental outcome of interest relates to the need 
for the presence of impairment (Healey, Miller, 
Castelli, Marks, & Halperin, 2008). It is unclear 
whether to focus on; (i) the disorder per se (i.e., 
symptoms plus impairment); (ii) impairment (even with 
insufficient symptoms); or (iii) the syndrome (i.e., a 
constellation of symptoms even if there is insufficient 
impairment for the diagnosis)? From a scientific 
perspective the syndrome is probably most important in 
that it is the most direct and specific outcome of the 
causal processes. However, from a ‘clinical’ point of 
view, it is impairment that justifies intervention. 
Given our focus on early intervention, it is important 
that we understand the factors that determine the onset 
of impairment and their relationship to the underlying 
causes of the syndrome. However, the concept of 
impairment is in many ways more problematic than the 
concept of syndrome (Gathje, Lewandowski, & Gordon, 
2008; Coghill, Danckaerts, Sonuga-Barke, Sergeant, & 
European Guidelines Group, 2009). Impairment is also a 
continuum and there are difficulties inherent in 
defining its onset in categorical terms. Furthermore the 
relationship between symptoms and impairment depend to a 
significant degree on the general cultural definition of 
what constitutes competence. Where expectations of 
performance/competence are highest impairment thresholds 
will be lowest. Our approach is to characterise 
impairment as a developmental complication of the 
syndrome, and then identify the factors that create a 
context for success or failure in everyday activities. 
In this sense, we can talk about a particular 
developmental phenotype with co-occurring impairment. 
Box 1 outlines what we hypothesize to be key 
elements to conceptualizing ADHD from a developmental 
perspective as described above.  It is from these 
central tenets that our proposal for early intervention 
emerges. 
_________________________ 
Insert Box 1 About Here 
_________________________ 
 
C: ADHD DEVELOPMENTAL PHENOTYPES AND EARLY CAUSAL 
PATHWAYS.  
I: Early-emerging developmental phenotypes of ADHD.  
There is an increased tendency for ADHD to be identified 
and diagnosed during the preschool years (Posner et al., 
2007; Egger, Kondo, & Angold, 2006; Healey et al., 
2008), although the vast majority of cases are 
identified in middle childhood. The existence of early- 
and later-emerging forms of ADHD highlights potential 
heterogeneity in ADHD developmental phenotypes. 
Furthermore it raises questions about the nature and 
significance of early-emerging symptoms and related 
impairment and the extent to which these are equivalent 
to later emerging forms. Are these early-emerging 
symptoms precursors of long-term difficulty, either 
through their persistence (homotypic continuity; Lahey, 
Pelham, Loney, Lee, & Willcutt, 2005) or their role as a 
precursor for other problems (i.e., heterotypic 
continuity; Lee, Lahey, Owens, & Hinshaw, 2008)?  From a 
clinical perspective it is important to avoid over-
pathologizing early indicators of ADHD if it can be 
shown that they resolve with time (Smith & Corkum, 
2007). On the other hand, we must not underestimate the 
clinical significance of early appearing signs of 
elevated, but sub-diagnostic or non-impairing symptoms, 
which may represent early indicators of a full-blown 
disorder (Sonuga-Barke, Stevenson, Thompson, & Viney, 
1997).  
 Early- and late-emerging forms of ADHD share many 
features. However, some researchers have adopted a more 
generic “hard to manage” classification, collapsing ADHD 
and conduct problems in relation to preschool 
expressions (e.g., Campbell, Pierce, March, Ewing, & 
Szumowski, 1994). The evidence for such a combined 
category is no stronger in the early years than it is in 
the school-age years as symptoms of ADHD (inattention, 
overactivity and impulsiveness) cluster together and are 
distinctive from, though overlapping with, symptoms of 
conduct problems (Fantuzzo et al., 2001; Gadow, Nolan, 
Sprakfin, & Schwartz, 2002; Sonuga-Barke et al., 1997; 
Pavuluri & Luk, 1998; Egger et al., 2006). Furthermore, 
patterns of association between these two domains seem 
similar in the preschool and the school-age period 
(Harvey, Friedman-Weieneth, Goldstein, & Sherman, 2007). 
The distinction between hyperactive-impulsive and 
inattentive symptom domains is fairly robust in the 
preschool period (Hardy et al., 2007), with some 
suggestion that inattention symptoms are the better 
predictor of later psychopathology (Smidts & Oosterlaan, 
2007). Three domains of impairment seem especially 
characteristic of early emerging ADHD; developmental 
delay, deficient pre-academic skills, poor social skills 
and problems establishing and maintaining close 
relationships (Kern et al., 2007).  
Longitudinal studies following-up children from the 
preschool period suggest only moderate continuity, with 
early-emerging ADHD symptoms persisting in only a 
proportion of cases (Lavigne et al., 1998; Mathiesen & 
Sanson, 2000). Persistence of problems in clinically-
referred samples is common, but most children identified 
as having a disorder in preschool have improved 
considerably by school entry (Campbell et al., 1994; 
Lavigne et al., 1998; Marakovitz & Campbell, 1998). A 
more general pattern of problems may persist even in 
those children for whom ADHD itself diminishes over time 
(Lee et al., 2008). There is both moderate homotypic and 
hetrotypic continuity. The possibility that early ADHD 
represents a risk for later conduct problems via 
parental responses to challenging behaviour and their 
potential to generate coercive cycles of parent-child 
interaction need also be considered (Chronis et al., 
2007). Interestingly environmental factors appear to 
operate differently for ADHD symptoms and aggression 
(Jester et al., 2005).  
Early indicators of later ADHD, rooted in subtle 
variations in infant characteristics, include neuro-
developmental immaturity, increased activity level, 
emotional dysregulation, over-responsivity to 
environmental stimulation, and lower cognitive 
functioning (Auerbach et al. 2005; Carlson, Jacobvitz, & 
Sroufe, 1995; Degangi, Porges, Sickel, & Greenspan, 
1993; Ebstein et al., 1998; Jacobvitz, & Sroufe, 1987; 
Morrell & Murray, 2003; Rende, 1993; Wolke, Rizzo, & 
Woods, 2002; Sanson, Smart, Prior, & Oberkland, 1993; 
Esser, Fischer, Wyschkorn, Laucht, & Schmidt, 2007a). 
However, once again the predictive power of these 
markers is generally weak. As children enter the 
preschool period ADHD severity is a significant 
indicator of the early emergence and persistence of ADHD 
(Wahlstedt, Thorell, & Bohlin, 2008; Leblanc et al., 
2008), which in some children may reflect a putative 
temperamental predisposition to problems of affect and 
cognitive regulation (Arseneault, et al., 2003; Caspi, 
Henry, McGee, Moffit, & Silva, 1995; Moffitt, 1993). The 
presence of oppositional and defiant behaviour is a 
predictor of the early emergence of impairment (Campbell 
et al., 1994; DuPaul, McGoey, Eckert, & VanBrakle, 2001; 
Keenan & Wakschlag, 2000; Speltz, McClellan, DeKlyen, & 
Jones, 1999). Early referral is most strongly predicted 
by defiance, tantrums, and aggression (Eyberg, Boggs, & 
Algina, 1995; Lavigne et al., 1998). Underlying 
neuropsychological impairment appears to be associated 
with continuity in ADHD rather than conduct problems 
(Brocki, Nyberg, Thorell, & Bohlin, 2007). Although the 
association between these two components is well-
established, much more research is required to tease 
apart the nature of their causal relationship (Jester et 
al., 2005).  
 Sonuga-Barke et al. (2005) suggested an 
illustrative developmental taxonomy as an aide to 
thinking about early developmental heterogeneity in 
ADHD.  Four phenotypes were postulated. In type I 
(Emergent Oppositionality) early sub-clinical pre-school 
ADHD, indicating a relatively low level of risk in and 
of itself, represents a risk factor for later 
oppositional problems with this link being moderated by 
the presence of coercive and negative parenting. In type 
II (Late onset ADHD), varying levels of early emerging 
ADHD symptoms remain sub-clinical during the early years 
but emerge in a clinically significant form either 
because the levels of symptoms are moderated upwards 
over time by environmental or genetic factors (Jester et 
al., 2005; Chronis et al., 2007), or because a change in 
setting creates a context for impairment not present 
earlier (e.g., as a child’s regulatory abilities are 
challenged by the demands of the classroom). Type III 
(Preschool limited ADHD) was hypothesized to be marked 
by moderate to high levels of early emerging ADHD 
symptoms and associated impairment with the pathways to 
long-term disorder being interrupted by protective 
features in the child's social environment at home 
and/or school (such as proactive, firm, limit-setting at 
home, an appropriately structured classroom). Here the 
downward spiral into poor outcome may be avoided. Type 
IV (Early-onset Chronic ADHD) was hypothesized to be 
marked by severe preschool ADHD and perhaps a 
temperamentally-based difficulty in mood regulation 
marked by temper-tantrums; problems interact to lead to 
early onset, chronic combined ADHD and oppositionality. 
A persistence of problem behaviours in these two domains 
is accompanied by increasing cycles of coercion within 
the family and in turn the exacerbation of the problems 
themselves. This framework although only suggestive, may 
provide a basis for exploring the configurations of 
associations and characteristics of the different 
patterns of emergence and persistence in ADHD 
developmental trajectories. The issue of whether such 
multiple developmental phenotypes should be regarded as 
discrete in any sense raises issues similar to those 
raised by the category v continuum debate more generally 
in relation to ADHD. In this sense the boundaries 
between early and late emerging symptoms and persisting 
and desisting phenotypes are likely to be no less fuzzy 
then those between disorder and no disorder, although 
there has been no direct empirical test of this as yet. 
To the extent that this is true, defining the specific 
boundaries between different developmental phenotypes 
within the broader ADHD domain will be no less arbitrary 
than for the ADHD diagnosis itself. However drawing 
distinctions between different developmental phenotypes 
provides us with a potentially useful scientific and 
clinical heuristic. It is in this spirit we promote a 
developmental typology to express ADHD heterogeneity.  
II: Putative causal underpinnings of early developmental 
phenotypes.   
There is currently little data of direct relevance 
to the issue of early, as opposed to late, emergence of 
ADHD, however we will attempt to draw out the possible 
implications of data collected with older children for 
our understanding of early developmental phenotypes.  
Originating risk: Identifying early risk factors for 
ADHD is complicated by the fact that ADHD, like other 
disorders, is probably the result of the interplay 
between genes and environment (e.g., gene-environment 
correlation and interaction) with effects operating in 
different ways in different individuals (i.e., 
aetiological heterogeneity). Although, highly heritable 
(Rietveld, Hudziak, Bartels, van Beijsterveldt, & 
Boomsma, 2003; Thapar, Harrington, Ross, & McGuffin, 
2000) ADHD is not a genetic disorder in a straight 
forward sense (Thapar, O’Donovan, & Owen, 2005; 
Asherson, Kuntsi, & Taylor, 2005). Evidence from 
candidate gene linkage and genome wide association 
studies is consistent with the notion that many genes of 
small effect are implicated in ADHD (Faraone et al., 
2005; Thapar et al., 2005; Arcos-Burgos et al., 2004; 
Hebebrand et al., 2006; Lasky-Su et al., 2008).  Pre- 
and perinatal environmental factors also appear to play 
an important role in the risk equation (Taylor & Rogers, 
2005) with more or less compelling evidence relating to 
maternal smoking (Thapar et al., 2003), alcohol 
consumption (Vaurio, Riley, & Mattson, 2008), use of 
drugs of abuse (Linares et al., 2006), deficient diet 
(Gale et al., 2008) and exposure to stress during 
pregnancy (Rodriguez & Bohlin, 2005; O’Connor, Heron, 
Golding, & Glover, 2003). Low birth weight and perinatal 
complications may also be risk markers (Bhutta, Cleves, 
Casey, Cradock, & Anand, 2002; Ben Amor et al., 2005). 
Effects of individual factors are small and 
inconsistent. Mechanisms proposed to account for these 
effects include biological programming in response to 
the adverse uterine environment (Swanson et al., 2007b), 
subtle brain damage due factors such as hypoxia 
(Halperin & Schulz, 2006; Lou, 1996) and the  
environmental moderation of genes effects (Mill & 
Petronis, 2008). Exposure to prenatal risk exposure 
appears to be moderated by polymorphisms in dopamine 
genes (e.g., Kahn, Khoury, Nichols, & Lanphear, 2003; 
Brookes et al., 2006; Becker, El-Faddagh, Schmidt, 
Esser, & Laucht, 2008; Todd & Neuman, 2007). Gene - 
environment effects may not be limited to the pre-natal 
physical environment with recent evidence of risk 
genotypes (e.g., 5-HTT-LPR) interacting with social 
adversity to increase ADHD risk (Retz et al., 2008; Reif 
et al., 2007; Sonuga-Barke et al., 2008c). Environmental 
exposures may moderate gene expression – i.e., ‘switch 
on’ or ‘switch off’ susceptibility gene (Mill & 
Petronis, 2008) or a gene may alter risk-exposure 
patterns, or increase resilience to adverse events 
(Belsky, Fearon, & Bell, 2007). Assessing the 
significance of genetic and environmental factors and 
their interaction is complicated by the inevitable co-
variation of risks (gene-environment correlation) which 
have proved extremely challenging to tease apart (Taylor 
& Rogers, 2005) 
Psychopathophysiological mediators: ADHD children’s 
brains are smaller on average than their peers 
(Castellanos et al., 2002), with differences emerging in 
the cerebellum, as well as several cortical and 
subcortical regions (Valera, Faraone, Murray, & Seidman, 
2007; Ellison-Wright, Ellison-Wright, & Bullmore, 2008). 
Delays in maturation are apparent throughout the cortex 
during the school years (Shaw et al., 2006; 2007), and 
adults with ADHD appear to have differential cortical 
thinning in prefrontal regions (Makris et al., 2007). 
ADHD is also associated with altered catecholamine 
functioning (Oades et al., 2005; Pliszka, 2005; but see 
Gonon, 2009) with PET studies suggesting abnormal 
dopamine receptor functioning, although findings have 
not been consistent (Spencer et al. 2007; Volkow et al., 
2007a; 2007b). Crucially, neural networks which underpin 
higher cognitive processes are modulated by DA and NE 
branches, and medications which act on catecholamines, 
improve functioning across several neuropsychological 
domains deficient in ADHD (e.g., Turner, Blackwell, 
Dowson, McLean, & Sahakian, 2005; Bush et al., 2008). 
The catecholamine hypothesis is further supported by 
genetic studies (Faraone et al., 2005) and by knock-out 
and lesion animal models (Arnsten & Li, 2005; Madras, 
Miller, & Fischman, 2005). Although this pattern of 
circumstantial evidence has convinced many of the causal 
role of catecholamine dysregulation, and dopamine 
deficits in particular (Swanson et al., 2007b), the 
possibility that neuro-chemical effects could be the 
marker of some more fundamental neuro-biological effect 
needs to be born in mind (Madras, Miller, & Fischman, 
2002), as must the complex way in which neuro-
transmitters interact (Olijslagers, Werkman, McCreary, 
Kruse, & Wadman, 2006). 
  Consistent with evidence of alterations to brain 
regions implicated in cognitive control, ADHD is often 
seen as an executive function disorder. It is associated 
with a range of neuropsychological deficits in EF 
domains (Willcutt, Doyle, Nigg, Faraone, & Pennington, 
2005); deficits linked to pre-frontal hypo-activation in 
the frontal cortex (Rubia, et al., 1999; Durston et al., 
2003; Fallgatter et al., 2005) and the neo-striatum 
(i.e., caudate and putamen; Rubia et al., 1999; Vaidya, 
Bunge, Dudukovic, & Zalecki, 2005). Reduced functional 
connectivity in key brain regions associated with EF has 
been observed (Castellanos et al., 2008). Understanding 
executive deficits in ADHD is complicated by the fact 
that; (i) effect sizes are moderate at best (Nigg et 
al., 2005); (ii) children with disorders other than ADHD 
show executive dysfunctions (Geurts, Vertie, Osterlann, 
Roeyers, & Sergeant, 2004); (iii) adequate performance 
on most executive function tasks are dependent upon more 
basic cognitive processes that have been shown to be 
deficient in ADHD (e.g., visual memory - Rhodes, 
Coghill, & Matthews, 2004; timing - Smith, Taylor, 
Rogers, Newman, & Rubia, 2002; basic attentional 
mechanisms - Booth, Carlson, & Tucker, 2007; motor 
coordination - Carte, Nigg, & Hinshaw, 1996).  
 ADHD performance seems also highly sensitive to changes 
in motivational context and the state of the individual (see 
below; Sergeant, 2005; Luman, Oosterlaan, & Sergeant, 2005;  
Sonuga-Barke, Wiersema, van der Meere, Roeyers, in press).  
ADHD children show altered processing of motivational stimuli 
(e.g., rewards and punishments; Luman et al., 2005), 
especially when delayed (e.g., Marco et al., 2009), an effect 
explained in terms of altered reward signalling (Sagvolden et 
al., 2005; Tripp & Wickens, 2008) and/or an aversion to delay 
(Sonuga-Barke et al., 2008a). The brain circuits implicated 
here, although functionally and structurally distinct from 
executive circuits, are heavily modulated by dopamine and 
there is evidence for altered brain activations to rewards in 
ADHD (Scheres et al., 2006; Ströhle et al., 2008; Plitcha et 
al., 2009). ADHD patients may also suffer from state 
regulation deficits (Sergeant, 2005). ADHD appears 
psychopathophysiologically, as well as aetiologically 
heterogeneous.  
Moderating environmental factors: Central to our 
case for the power of early intervention in ADHD is that 
causal pathways are amenable to environmental 
manipulations. Evidence for this comes from a number of 
sources. Early institutional exposure (Rutter et al., 
2007) is associated with increased rates of ADHD 
(Stevens et al., 2008; Sonuga-Barke & Rubia, 2008). 
Evidence also suggests that the family environment might 
determine the course and persistence of the condition. 
ADHD appears to elicit negative, intrusive and harsh 
parenting (Seipp & Johnston, 2005), while inappropriate 
parenting can exacerbate ADHD itself (e.g. Morrell & 
Murray, 2003). Belsky et al. (2007) found that reduced 
maternal sensitivity was associated with poorer 
attention later in childhood. Inappropriate parenting 
towards ADHD children in middle childhood is associated 
with the onset of comorbid conduct disorder (Taylor, 
Chadwick, Heptinstall, & Danckaerts 1996) and depression 
(Ostrander & Herman, 2006).   
The physical/chemical post-natal environment may 
also be important. Diet may play a more significant role 
than once thought (McCann et al., 2007). Evidence for a 
role for malnutrition and dietary deficiency is limited 
(Sonuga-Barke et al., 2008b; Konofal, Lecendreux, 
Arnulf, & Mouren, 2004), but fatty acid intake may play 
a role (Richardson & Montgomery, 2005). Low level 
exposure to lead (Nigg et al., 2008) and to toxins, such 
as those contained in insecticides, have also been noted 
as possibly important (Mariussen & Fonnum, 2006). Early 
exposure to psychostimulants might also be associated 
with long-term adaptations and alterations to the brain 
(Grund, Lehman, Bock, Rothenberger, & Teuchert-Noodt, 
2006), some of which may have therapeutic potential 
(Dommett, Henderson, Westewell, & Greenfield, 2008).  
III: Developmental similarities and continuities in 
psychopathophysiology.  
Early intervention targets are only of value if we 
can be confident of the similarity between, and the 
continuity of, causal factors across development. Given 
the paucity of relevant studies in early development we 
have only a fragmented picture of the neuro-psychology 
and –biology associated with early developmental 
phenotypes. In general the neuropsychological data 
support the existence of both (i) executive deficits and 
related cognitive problems (Seidman, 2006), (ii) 
motivational and (iii) energetical abnormalities across 
different periods of the lifespan (Marco et al., 2009; 
Wiersema, van der Meere, Antrop, & Roeyers, 2006). 
Evidence in relation to these types of deficits in early 
onset forms comes from a number of sources (Thorell, 
2007; Sonuga-Barke et al., 2003b; Marks et al., 2005; 
Berwid et al. 2005), and these could be investigated 
further as early treatment targets. However, due to a 
dearth of neuropsychological longitudinal studies we 
know little regarding continuities between early and 
later deficits.  Halperin at al. (2008) found that 
continuity between childhood and adolescent ADHD was 
associated with the presence of underlying deficits in 
cognitive efficiency and regulation combined with the 
failure to develop effective higher order control. This 
finding is consistent with the notion that recovery from 
ADHD is associated with improvements in executive 
control functions (Halperin & Schulz, 2006).  However, 
the direction of causation remains unclear – do improved 
executive functions yield a reduction in ADHD severity  
as posited by Halperin and Schulz (2006) or are 
executive impairments epiphenomenal and remit in concert 
with ADHD symptoms over development (Carr, Nick, & 
Henderson, 2006)? Preliminary functional magnetic 
resonance imaging (fMRI) findings indicate that 
prefrontal activation in response to inhibition in 
adolescents with childhood ADHD corresponds to the 
persistence of symptoms (Schulz, Newcorn, Fan, Tang, & 
Halperin, 2005a; Schulz, Newcorn, Fan, Tang, & Halperin, 
2005b). In studies of the transition from early to late 
manifestations of the disorder early appearing cognitive 
deficits predict disorder persistence (Wahlstedt et al., 
2008; von Stauffenberg & Campbell, 2007). There have 
been no studies of developmental continuity in 
motivational or energetical processes over this period 
to our knowledge.  
 IV: Developmental heterogeneity: Do multiple causal 
pathways underpin the diversity of developmental 
phenotypes?  
Evidence for heterogeneity in the psychopathophysiology 
of ADHD, as well as in developmental phenotypes and 
clinical presentations, is growing. Consistent with 
this, pathophysiological subtypes – either at the level 
of etiological factors (Swanson et al., 2007b) or 
underlying neuropsychology (Sonuga-Barke, 2005; Nigg et 
al., 2005), have been proposed. Sonuga-Barke et al., 
(2003a) studied executive deficits and motivational 
alterations (i.e., delay aversion) in a group of pre-
school children. Some children had executive dysfunction 
but no delay aversion while others delay aversion but no 
executive dysfunction. Thorell (2007) also found that 
delay aversion and inhibitory control were distinctive 
components in a preschool sample and had different 
developmental outcomes. This together with similar data 
from samples of older children (Solanto et al., 2001; 
Toplak, Jain, & Tannock, 2005) and animal models (Van 
den Bergh et al., 2006)raises the question of whether 
there are delay averse and executive dysfunction 
subtypes of ADHD (Sonuga-Barke et al., 2008a).  
These distinctions in individuals suggest 
differential development pathways – perhaps each with 
its own originating causes, mediating mechanisms and 
environmental moderators and perhaps each marked by a 
different developmental phenotype (pattern of emergence, 
persistence and outcome). However, testing whether such 
pathways are distinctive in terms of either disorder 
expression or underlying causes requires a new 
perspective on ADHD and a new programme of research. 
Crucially, we know almost nothing about the specificity 
of the relationship between different potential 
etiological factors, patho-physiological processes and 
phenotypic outcomes (but see Thorell, 2007). Further, 
cognitive and motivational factors inevitably interact 
throughout development (Castellanos, Sonuga-Barke, 
Milham, & Tannock, 2006), a fact that clearly 
complicates the task of identifying markers of different 
cognitive and motivational pathways.  
Heterogeneity in developmental pathways has 
critical implications for early intervention strategies. 
First, no one treatment target is likely to be relevant 
for every individual and different treatments addressing 
different deficits are likely to be differentially 
effective. Second, and following on from this, effective 
early intervention may rely on identifying which 
treatment targets and therefore which treatments are 
most relevant for a particular child. 
Box 2 summarizes our hypotheses linking causal 
pathways, developmental phenotypes and the belief that 
these factors are susceptible to environmental 
influences.  Together these form the rationale for the 
putative affects of early intervention across the 
lifespan. 
_________________________ 




D: REFLECTIONS ON EARLY IDENTIFICATION AND INTERVENTION 
AS A BASIS FOR THERAPEUTIC INNOVATION.  
Above we have set-out a rationale for the hypothesis 
that early intervention for ADHD can be effective if it 
targets early causal pathways to alter the underlying 
pathophysiology of the disorder and produce persistent 
and generalised change (cf. Dawson, 2008). To test this 
hypothesis we need first to be able to differentiate 
those youngsters who require intervention from those 
that don’t, to carry out assessments to match children 
with the right intervention (given the range of 
developmental phenotypes and pathways), and then to 
develop interventions that can successfully target the 
underlying causes of the emerging disorder. Throughout 
this article we have highlighted the lack of directly 
relevant empirical evidence and the need for additional 
research with regard to this approach; the early 
intervention approach for ADHD still requires proof of 
concept. The empirical study of early assessment and 
intervention in ADHD is therefore still in its infancy 
(cf. Kern et al., 2007). Early intervention studies have 
adopted standard pharmacological (Greenhill, Posner, 
Vaughan, & Kratochvil, 2008) and/or generic family-based 
models (Jones et al. 2008). These approaches have 
produced clinical improvements (Ghuman, Arnold, & 
Anthony, 2008), but the extent to which they “correct” 
negative developmental trajectories, the gold standard 
test of an effective early intervention strategy, is 
currently not known. Further, there have been few 
attempts to develop methods for identifying ‘children at 
risk for ADHD’ and no attempt to identify different 
developmental phenotypes. There has been little or no 
systematic assessment of feasibility, effectiveness or 
cost effectiveness of broad-based early intervention 
strategies as has occurred for other conditions (Gill, 
Hyde, Shaw, Dishion, & Wilson, 2008). In this section we 
are therefore necessarily limited to reflecting both on 
the principles that should govern early identification 
and intervention approaches in ADHD, while looking at 
how these principles can be put into practice more 
effectively.  
I: Can we identify children who might benefit from early 
intervention?  
 While we have data on early risk indicators, 
especially for persistence of early established disorder 
(Brocki et al., 2007), far more research is needed into 
the indicators of ADHD trajectories as well as their 
practical clinical value (Esser et al., 2007b). The task 
of early identification of individuals at risk is 
complicated by at least three factors; (i) the 
interactive way in which risks operate; (ii) the non-
deterministic way in which these factors seem to be 
related to possible (endo)phenotypic indicators of risk; 
and (iii) the incomplete patterns of continuity from 
early phenotypic indicators to later disorder – i.e., 
only some young children showing initial symptoms and/or 
impairment go on to have later problems. Can we predict 
different patterns of emergence, persistence and 
remission of disorder?  
In the prevention literature a distinction is drawn between 
primary, secondary and tertiary prevention. Primary prevention 
stops the development of disease process before it occurs. 
Secondary prevention involves attempts to inhibit the progress 
from early signs to the development of the syndrome. Tertiary 
prevention works reduces impairment in those already affected. 
The feasibility of each level of prevention depends on whether 
risk can be assessed effectively at different points across 
development. First, in relation to targeted primary 
intervention we need to consider indicators of originating 
risk (Esser et al., 2007a). Using genetic and pre-/peri-natal 
environmental risk markers, in principle, intervention can 
begin very early – perhaps even before phenotypic patterns 
emerge. However, given current knowledge about the predictive 
power of these risk markers, predicting developmental outcome 
on the basis of originating risks is currently not possible 
(Esser et al., 2007b). Therefore genetic or prenatal screening 
is not a viable basis for early targeting of interventions. It 
also raises ethical issues of a most serious nature (Yeh, 
Morley, & Hall, 2004). More fundamentally, given this and the 
synergistic way in which genetic and pre- and post-natal 
environmental risks interact in non-deterministic ways, it is 
unlikely that assessing risk for ADHD on the basis of genetic 
screening will ever be desirable or possible (Kerruish & 
Robertson, 2005).  
 Secondary intervention based on the identification 
of early phenotypic indicators may represent a more 
promising approach for early risk profiling. Key 
predictors appear to include putative temperamental 
hyperactivity (Wahlstedt et al., 2008), co-occurring 
problems in other domains (especially mood regulation; 
Esser et al., 2007a) and early underlying 
neuropsychological impairment (Brocki et al., 2007). 
Negative parenting may also portend persistence (Jester 
et al., 2005). The predictive value of these different 
markers may increase with age.  Esser et al. (2007a) 
reported that measures of temperamental dysregulation 
were better predictors at 24 than 12 months. The overall 
risk associated with the diverse biological and 
environmental factors which these indicators mark has 
not been systematically quantified, nor has its 
practical value as a basis for early intervention been 
assessed.  
As far as tertiary prevention is concerned early 
emerging, severe and impairing ADHD is a predictor of 
persistence at least into the school years. Lahey et al. 
(2004) found that up to 80 percent of children who met 
criteria for preschool ADHD with pervasive functional 
impairment continued to have problems as they entered 
the school years. However, in this case the ‘full’ 
disorder was to all intents and purposes already present 
and it could be argued that treatment would be justified 
on the basis of the presence of the disorder itself at 
that time, rather than in terms of what it predicted 
about the future.  
The Lahey data also highlight the existence of 
children who do not show persistence despite exhibiting 
early emerging and severe patterns (i.e., the 
diminishing pattern described by Sonuga-Barke et al., 
2005). A key question therefore is whether this group 
can be identified. Currently limited data preclude the 
ability to identify factors that moderate pathways to 
produce this early emerging diminishing phenotype. 
However, if we could distinguish ‘time limited’ and 
persistent forms of early-emerging ADHD then one would 
be unlikely to employ as aggressive and comprehensive 
(and costly) intervention approach for the former as for 
the latter group (Sonuga-Barke et al., 2005).  
 Even less is known of the factors that determine 
late- than early-emerging patterns. Again genetic 
factors may play a role but school entry may be an 
especially important provoking factor. Some children may 
be especially vulnerable to the impact of the transition 
from home environment to the more rigorous demands of 
the classroom setting. The therapeutic value of managing 
the home-to-school transition for some children has not 
been studied.  
 For those children whose temperamentally-driven 
hyperactivity is a risk for the development of conduct 
problems but not ADHD, markers of potential risk are 
likely to be as much in the negative interaction within 
the pre-school family environment as they are to be 
characteristics of the child (Burke, Pardini, & Loeber, 
2008; Degnan, Calkins, Keane, & Hill-Soderlund, 2008; 
Chronis et al., 2007). Here parent training packages may 
be especially fruitful. There is a growing literature 
suggesting effective early identification and 
intervention strategies can target these sorts of 
children effectively (Gill et al., 2008).  
Given the possible eventual clinical significance 
of sub-clinical problems manifested during the preschool 
years, effective early intervention strategies may need 
to include some element of universal screening. 
Screening assessment for ADHD is less developed than for 
other disorders (Hill, Lochman, Coie, Greenberg, & 
Conduct Problems Prevention Research Group, 2004). The 
heterogeneity of developmental phenotypes further 
complicates the already difficult task of identifying 
risk factors because screening tasks ideally should 
identify predictors of later disorder and distinguish 
between different trajectories of disorder emergence and 
persistence. Given this, it is possible that such 
screening will need to focus not only on symptoms but 
intellectual delay, neuropsychological deficits and the 
family environment. Overall, targeted primary 
intervention is unlikely to be feasible. Furthermore, 
our current understanding of early markers of later 
disorder onset and disorder persistence is insufficient 
to provide accurate targeting of secondary prevention. 
Tertiary intervention seems potentially more feasible 
but better models of early predictors of long term 
impairment and burden are still required.  
 
II: Can we develop effective early interventions 
that target the putative causal pathways underpinning 
ADHD developmental phenotypes? 
Evidence suggests a more limited efficacy of 
psychostimulants with preschoolers than older children 
(Kollins & Greenhill, 2006).  The “Preschool ADHD 
Treatment Study” (Greenhill et al., 2006) found that 
overall methylphenidate was superior to placebo and 
generally well-tolerated. Positive effects were less 
consistent and more reduced in the presence of 
comorbidity (Ghuman et al., 2007) to a greater degree 
than is the case with older children. Side-effects and 
adverse events were common (Wigal et al., 2006) and a 
large proportion of patients failed to complete a 10 
month continuation phase (Vitiello et al., 2007). Some 
evidence also exists for the value of non-stimulants 
with younger ADHD children (Kratochvil et al., 2007). 
Crucially, there is no evidence that early medication 
either reduces the persistence of ADHD or mitigates the 
full onset of the disorder in sub-clinical cases. The 
role of medication in early intervention strategies 
remains to be defined.  
 Other considerations aside, medication is likely to 
remain a controversial option for preschoolers and early 
intervention is likely to rely on developing effective 
non-pharmacological interventions. There are a range of 
non-pharmacological options (including child centred 
cognitive behavioural and cognitive approaches; Toplak, 
Connors, Shuster, Knezevic, & Parks, 2008) but psycho-
social interventions delivered by parents and teachers 
are most commonly used. In particular, it has been 
argued that parent training packages based on generic 
social learning approaches (Forehand & McMahon, 1981) 
e.g. Parent-Child Interaction Therapy (Eyberg, Boggs, & 
Algina, 1995),the Incredible Years; (Webster-Stratton, 
Reid, & Hammond, 2001) or Triple P (Bor, Sanders, & 
Markie-Dadds, 2002), when appropriately adapted for use 
with ADHD children represent a useful treatment option. 
These approaches reduce levels of oppositionality, 
defiance and conduct problems in children and improve 
mental health in their parents (Serketich & Dumas, 
1996), effects that generalise to the ADHD population 
(Hartman, Stage, & Webster-Stratton, 2003). Improvements 
seen at home do not necessarily generalize to other 
settings (Taylor & Biglan, 1998). In non-referred groups 
of preschoolers with hard-to-manage behaviour, generic 
parent training approaches may improve parent-rated 
attention problems (Bor et al., 2002; Strayhorn & 
Weidman, 1989; Jones et al., 2008. However, as in the 
case with older children (reviewed in Hinshaw, Klein, & 
Abikoff, 1998; 2002; McGoey et al., 2002), findings with 
preschoolers with severe ADHD symptoms are less 
convincing (Barkley et al., 2000; Pisterman et al., 
1989; 1992). As with medication in preschoolers, nothing 
is known of whether parenting approaches can alter 
trajectories and improve outcomes over the longer term. 
 What can be done to optimize the impact of early 
non-pharmacological strategies? In this article we have 
set out the hypothesis that therapeutic innovations that 
target the underlying causal processes are likely to be 
most effective. For instance, the failure of children to 
develop effective executive control has been proposed as 
a putative cause of ADHD (Nigg et al., 2005), at least 
for a sub-group of children, with measurable deficits 
being present by the age of three years (Brocki et al., 
2007).  
Computerised cognitive training can improve 
attentional control in neuro-psychological 
rehabilitation (Michel & Mateer 2006; O’Connell et al., 
2008). The case for its use to target alterations in 
developing neural systems is less clear. However, a 
compelling case for such an approach was made by Rueda 
et al., (2005) based on the notion that developing 
attention circuitry was particularly amenable to 
experience between the ages of 3 and 7. This is 
consistent with studies of dyslexia (Chenault, Thomson, 
Abbott, & Berninger, 2006), language impairment (Stevens 
et al., 2008) and school readiness (Diamond, Barnett, 
Thomas, & Munro, 2007). With regard to ADHD there are 
studies of working memory training in school-age 
children (Klingberg et al., 2005) as well as other forms 
of attention training focusing on a wider range of 
cognitive skills may also have value (Toplak et al., 
2008). Preliminary data indicate that training produces 
improvements in working memory and other cognitive 
domains, although evidence that these effects translate 
in changes in ADHD symptoms is less clear-cut (Klingberg 
et al., 2005). Studies with adults suggest that these 
effects are associated with increased prefrontal and 
parietal activation (Klingberg et al., 2005) and changes 
in dopamine function (McNab et al., 2009). This training 
approach has recently been implemented with younger 
children (Thorell, Lindqvist, Nutley, Bohlin, & 
Klingberg, 2009) although effects did not generalise to 
other executive functions. More research in these groups 
is required before such approaches can be recommended as 
treatment elements in an ADHD early intervention 
programme.  
In the preschool years it may be more effective to  
embed cognitive enhancement within a general parent 
training approach. Such a delivery system may better 
match the needs of young ADHD children. For instance, in 
the New Forest Parenting Programme (NFPP) developed as a 
specialized psychological intervention for preschool 
children with ADHD (Sonuga-Barke et al., 2006), a 
cognitive element has been included to improve 
attentional control, working memory and general self-
regulation.  This relies on the primary caregiver to 
carry-out activities and home work exercises intended to 
enhance certain regulatory skills and promote executive 
function development.  By making the parent the agent-
of-change and integrating training within everyday 
activity it was hoped that maintenance of effects over 
time and generalization across settings would be 
optimised. The parent becomes the promoter of 
psychological growth within the child. The approach is 
implemented using games requiring attention, 
concentration, turn-taking, working memory and delay of 
gratification. The parent is also encouraged to use 
real-world situations that call for the use of the 
regulatory skills being taught (i.e., teachable 
moments). This naturalistic behavioural teaching 
approach provides numerous opportunities for 
generalization, a central concern and goal in the 
behavioural treatment of children with ADHD. A recent 
small scale randomised controlled trial of this 
intervention implemented with 3 to 5 year-olds with ADHD 
reported large effects on core symptoms of ADHD 
(Thompson et al., 2009).  
 A related approach (“Training Executive, Attention 
and Motor Skills; TEAMS), being developed by Halperin, 
Healey and collaborators (unpublished), similarly 
focuses on the development of a wide array of higher 
cognitive and motor skills in preschoolers with ADHD 
through the use of game-like activities that are 
presented to children in small group settings.  As with 
NFPP, parents are used as facilitators of practice and 
generalization.   
 The causal heterogeneity of ADHD means that 
different treatment targets are likely to be relevant 
for different children given that similar developmental 
phenotypes might be underpinned by different patterns of 
neuro-psychological and/or family dysfunction. Given the 
heterogeneity at some future point in time there may be 
value in neuropsychological testing to identify 
different core deficits and help tailor treatments.  
However, first we need to establish a clearer picture of 
the neuropsychological underpinnings of different 
developmental phenotypes and then we need to develop 
easy to implement, valid and reliable indices of 
different aspects of neuropsychological impairment as 
they manifest in ADHD. Training approaches to target 
different deficits, similar to those employed for 
working memory, are feasible. For instance, Sonuga-Barke 
(2004) has argued that operant techniques of fading and 
shaping may be an especially good way of altering 
incentive structures and improving delay behaviour 
(Neef, Bicard and Endo, 2001). However, until and unless 
such clearly-defined developmental phenotypes are 
identified and differentially validated, a more broad-
based approach that strives to enhance multiple 
potential ‘causal’ domains of functioning, as in NFPP 
and TEAMS, may represent a more optimal starting point 
for the development of novel prevention interventions. 
As outlined in Box 3, we propose several key elements 
that might form the basis or conceptual framework for 
the development of novel prevention intervention 
programs that might mitigate the severity of ADHD across 
the lifespan.      
Nevertheless, far more research is necessary to 
determine whether early intervention can be effectively 
implemented to alter the adverse course typically 
associated with ADHD across the lifespan.  Box 4 
outlines what we believe to be key issues that need to 
be clarified by future research. Such research, in turn, 
will greatly facilitate the eventual development of 
effective prevention interventions for ADHD as we have 
conceptualized it. 
___________________________________ 




In summary, we propose that early identification and 
intervention can be an effective basis for innovation 
for the treatment of ADHD if it can target the 
underlying causal mechanisms responsible for the 
disorder. Brain plasticity during early development and 
the moderated and mediated nature of ADHD outcomes 
highlight the potential of such an approach. However, 
more research is needed to characterise early 
developmental phenotypes of ADHD and their underlying 
causal processes to improve early identification of 
young children at risk, to identify treatment targets, 
and to develop new and innovative therapeutic approaches 
that have the potential to fundamentally alter 
developmental outcomes.  
 References 
Antshel, K. M., & Barkley, R. (2008). Psychosocial 
interventions in attention deficit hyperactivity 
disorder. Child and Adolescent Psychiatric Clinics 
of North America, 17, 421-+.  
Arcos-Burgos, M., Castellanos, F. X., Pineda, D., 
Lopera, F., Palacio, J. D., Palacio, L. G., et al. 
(2004). Attention-deficit/hyperactivity disorder in 
a population isolate: Linkage to loci at 4q13.2, 
5q33.3, 11q22, and 17p11. American Journal of Human 
Genetics, 75, 998-1014.  
Arnsten, A. F. T., & Li, B. M. (2005). Neurobiology of 
executive functions: Catecholamine influences on 
prefrontal cortical functions. Biological 
Psychiatry, 57, 1377-1384.  
Arseneault, L., Moffitt, T.E., Caspi, A., Taylor.A., 
Rijsdijk, F.V., Jaffee, S.R., et al. (2003). Strong 
genetic effects on cross-situational antisocial 
behaviour among 5-year-old children according to 
mothers, teachers, examiners-observers and twins’ 
self reports. Journal of Child Psychology and 
Psychiatry, 44, 832-848. 
Asherson, P., Kuntsi, J., & Taylor, E. (2005). 
Unravelling the complexity of attention-deficit 
hyperactivity disorder: a behavioural genomic 
approach. British Journal of Psychiatry, 187, 103-
105. 
Auerbach, J. G., Landau, R. Berger, A., Arbelle, S., 
Faroy, M., & Karplus, M. (2005). Neonatal behavior 
of infants at familial risk for ADHD. Infant 
Behavior & Development, 28, 220-224.  
Banaschewski, T., Coghill, D., Santosh, P., Zuddas, A., 
Asherson, P., Buitelaar, J., et al. (2006). Long-
acting medications for the hyperkinetic disorders – 
A systematic review and European treatment 
guideline. European Child & Adolescent Psychiatry, 
15, 476-495.  
Barkley, R. A., Shelton, T. L., Crosswait, C., 
Moorehouse, M., Fletcher, K., Barrett, S., et al. 
(2000). Multi-method psycho-educational intervention 
for preschool children with disruptive behavior: 
Preliminary results at post-treatment. Journal of 
Child Psychology and Psychiatry and Allied 
Disciplines, 41, 319-332.  
Beauchaine, T. P., Neuhaus, E., Brenner, S. L., & Gatke-
Kopp, L. (2008). Ten good reasons to consider 
biological processes in prevention and intervention 
research. Development and Psychopathology, 20, 745-
774.  
Becker, K., El-Faddagh, M., Schmidt, M. H., Esser, G., & 
Laucht, M. (2008). Interaction of dopamine 
transporter genotype with prenatal smoke exposure on 
ADHD symptoms. Journal of Pediatrics, 152, 263-269.    
Bellgrove, M. A., O’Connell, R. G., & Vance, A. (2008). 
Genetics of cognitive deficits in ADHD: clues for 
novel treatment methods. Expert Review of 
Neurotherapeutics, 8, 553-561.  
Belsky, J., Fearon, R. M. P., & Bell, B. (2007). 
Parenting, attention and externalizing problems: 
testing mediation longitudinally, repeatedly and 
reciprocally. Journal of Child Psychology and 
Psychiatry, 48, 1233-1242.  
Ben Amor, L., Grizenko, N., Schwartz, G., Lageix, P., 
Baron, C., Ter-Stepanian, M., et al. (2005). 
Perinatal complications in children with attention-
deficit hyperactivity disorder and their unaffected 
siblings. Journal of Psychiatry and Neuroscience, 
30, 120-126. 
Berger, I., Dor, T., Nevo, Y., & Goldzweig, G. (2008). 
Attitudes toward attention-deficit hyperactivity 
disorder (ADHD) treatment: Parents' and children's 
perspectives. Journal of Child Neurology, 23, 1036-
1042.  
Berwid, O. G., Kera, E. A. C., Marks, D. J., Santra, A., 
Bender, H. A., & Halperin, J. M. (2005). Sustained 
attention and response inhibition in young children 
at risk for Attention Deficit/Hyperactivity 
Disorder. Journal of Child Psychology and 
Psychiatry, 46, 1219-1229.  
Bhutta, A. T., Cleves, M. A., Casey, P. H., Cradock, M. 
M., & Anand, K. J. S. (2002). Cognitive and 
behavioral outcomes of school-aged children who were 
born preterm - A meta-analysis. Journal of the 
American Medical Association, 288, 728-737. 
Bischof, H. J. (2007). Behavioral and neuronal aspects 
of developmental sensitive periods. Neuroreport, 18, 
461-465.  
Booth, J. E., Carlson, C. L., & Tucker, D. M. (2007). 
Performance on a neurocognitive measure of alerting 
differentiates ADHD combined and inattentive 
subtypes: A preliminary report. Archives οf Clinical 
Neuropsychology, 22, 423-432. 
Bor, W., Sanders, M. R., & Markie-Dadds, C. (2002). The 
effects of the Triple P-Positive Parenting Program 
on preschool children with co-occurring disruptive 
behavior and attentional/hyperactive difficulties. 
Journal of Abnormal Child Psychology, 30, 571-587. 
Brocki, K. C., Nyberg., L., Thorell, L. B., & Bohlin, G. 
(2007). Early concurrent and longitudinal symptoms 
of ADHD and ODD: relations to different types of 
inhibitory control and working memory. Journal of 
Child Psychology and Psychiatry, 48, 1033-1041.  
Brookes, K. J., Mill, J., Guindalini, C., Curran, S., 
Xu, X. H., Knight, J., et al. (2006). A common 
haplotype of the dopamine transporter gene 
associated with attention-deficit/hyperactivity 
disorder and interacting with maternal use of 
alcohol during pregnancy. Archives of General 
Psychiatry, 63, 74-81 
Burke, J. D., Pardini, D. A., & Loeber, R. (2008). 
Reciprocal relationships between parenting behavior 
and disruptive psychopathology from childhood 
through adolescence. Journal of Abnormal Child 
Psychology, 36, 679-692.  
Bush, G., Spencer, T. J., Holmes, J., Shin, L. M., 
Valera, E. M., Seidman, L. J., et al. (2008). 
Functional magnetic resonance imaging of 
methylphenidate and placebo in attention-
deficit/hyperactivity disorder during the multi-
source interference task. Archives of General 
Psychiatry, 65, 102-114. 
Campbell, S. B., Pierce, E. W. March, C. L., Ewing, L. 
J., & Szumowski, E. K. (1994). Hard-to-manage 
preschool boys – Symptomatic behavior across 
contexts and time. Child Development, 65, 836-851.  
Carlson, E. A., Jacobvitz, D. J., & Sroufe, L. A. 
(1995). A developmental investigation of 
inattentiveness and hyperactivity. Child 
Development, 66, 37-54. 
Carr, L. A., Nigg, J. T., & Henderson, J. M. (2006). 
Attentional versus motor inhibition in adults with 
attention deficit hyperactivity disorder. 
Neuropsychology, 20, 430-441. 
Carte, E., Nigg, J., & Hinshaw, S. (1996). 
Neuropsychological functioning, motor speed, and 
language processing in boys with and without ADHD. 
Journal of Abnormal Child Psychology, 24, 481-498. 
Caspi, A., Henry, B., McGee, R.O., Moffitt, T.E. & 
Silva, P.A. (1995). Temperamental origins of child 
and adolescent behavior problems – from age 3 to age 
15. Child Development, 66, 55 – 68. 
Castellanos, F. X., Margulies, D. S., Kelly, C., Uddin, 
L. Q., Ghaffari, M., Kirsch, A., et al. (2008). 
Cingulate-precuneus interactions: A new locus of 
dysfunction in adult attention-deficit/hyperactivity 
disorder. Biological Psychiatry, 63, 332-337.  
Castellanos, F. X., Sonuga-Barke, E. J. S., Milham, M. 
P., & Tannock, R. (2006). Characterizing cognition 
in ADHD: beyond executive dysfunction. Trends in 
Cognitive Sciences, 10, 117-123.  
Castellanos, F.X., Lee, P.P., Sharp, W., Jeffries, N.O., 
Greenstein, D.K., Clasen, L.S., et al. (2002). 
Developmental trajectories of brain volume 
abnormalities in children and adolescents with 
attention-deficit/hyperactivity disorder. Journal of 
the American Medical Association, 288, 1740-1748.  
Chenault, B., Thomson, J., Abbott, R. D., & Berninger, 
V. W. (2006). Effects of prior attention training on 
child dyslexics’ response to composition 
instruction. Developmental Neuropsychology, 29, 243-
260.  
Chronis, A. M., Fabiano, G. A., Onyango, A. N., Pelham, 
W. E., Lopez-Williams, A., Chacko, A., et al. 
(2004). An Evaluation of the summer treatment 
program for children with attention-
deficit/hyperactivity disorder using a treatment 
withdrawal design. Behaviour Therapy, 35, 561-585. 
Chronis, A. M., Lahey, B. B., Pelham, W. E., Williams, 
S. H., Bauman, B. L., Kipp, H., et al. (2007). 
Maternal depression and early positive parenting 
predict future conduct problems in young children 
with attention-deficit/hyperactivity disorder. 
Developmental Psychology, 43, 70-82.  
Cicchetti, D., & Blender, J. A. (2006). A multiple-
levels-of-analysis perspective on resilience - 
Implications for the developing brain, neural 
plasticity, and preventive interventions. In  B. M. 
Lester, A. S. Masten, B. McEwen (Eds.), Resilience 
in Children (pp. 248-258). Annals of the New York 
Academy of Sciences, vol. 1094.  
Cicchetti, D., & Toth, S. L. (2009). The past achievements and 
future promises of developmental psychopathology: the 
coming of age of a discipline. Journal of Child Psychology 
and Psychiatry, 50, 16-25.  
Coghill, D., Danckaerts, M., Sonuga-Barke, E., Sergeant, 
J., & European Guidelines Group (2009). Practitioner 
Review: Quality of Life in Child Mental Health – 
Conceptual Challenges and Practical Choices. Journal 
of Child Psychology and Psychiatry.  
Corkum, P., Rimer, P., & Schachar, R. (1999). Parental 
knowledge of attention-deficit hyperactivity 
disorder and opinions of treatment options: impact 
on enrolment and adherence to a 12-month treatment 
trial. The Canadian Journal of Psychiatry, 44, 1043-
1048. 
Curry, S. H. (2008). Tranlational science: past, 
present, and future. Biotechniques, 44, II-VIII.  
Dawson, G. (2008). Early behavioral intervention, brain 
plasticity, and the prevention of autism spectrum 
disorder. Development and Psychopathology, 20, 775-
803.  
Degangi, G., Porges, S., Sickel, R., & Greenspan, S. 
(1993). Four year follow-up of a sample of 
regulatory disordered infants. Infant Mental Health 
Journal, 14, 330-343. 
Degnan, K. A., Calkins, S. D., Keane, S. P., & Hill-
Soderlund, A. L. (2008). Profiles of disruptive 
behaviour across early childhood: Contributions of 
frustration, physiological regulation, and maternal 
behaviour. Child Development, 79, 1357-1376. 
Diamond, A., Barnett, W. S., Thomas, J., & Munro, S. 
(2007). The early years - Preschool program improves 
cognitive control. Science, 318, 1387-1388.  
Dommett, E. J., Henderson, E. L., Westewell, M. S., & 
Greenfield, S. A. (2008). Methylphenidate amplifies 
long-term plasticity in the hippocampus via 
noradrenergic mechanisms. Learning & Memory, 15, 
580-586.  
DuPaul, G. J., McGoey, K. E., Eckert, T. L., & 
VanBrakle, J. (2001). Preschool children with 
attention-deficit/hyperactivity disorder: 
Impairments in behavioral, social, and school 
functioning. Journal of the American Academy of 
Child and Adolescent Psychiatry, 40, 508-515.  
Durston, S., Tottenham, N. T., Thomas, K. M., Davidson, 
M. C., Eigsti, I. M., Yang, Y. H., et al. (2003). 
Differential patterns of striatal activation in 
young children with and without ADHD. Biological 
Psychiatry, 53, 871-878.  
Ebstein, R., Levine, J., Geller, V., Auerbach, J., 
Gritsenko, I., & Belmaker, R. (1998). Dopamine D4 
receptor and serotonin transporter promoter in the 
determination of neonatal temperament. Molecular 
Psychiatry, 3, 238-246. 
Egger, H. L., Kondo, D. & Angold, A. (2006). The 
epidemiology and diagnostic issues in preschool 
attention-deficit/hyperactivity disorder - A review. 
Infants and Young Children, 19, 109-122.  
Ellison-Wright, I., Ellison-Wright, Z., & Bullmore, E. 
(2008). Structural brain change in Attention Deficit 
Hyperactivity Disorder identified by meta-analysis. 
BMC Psychiatry, 8, 51. 
Engel, G. (1977). The need for a new medical model: a 
challenge for biomedicine. Science 196, 129-136.  
Esser, G., Fischer, S., Wyschkon, A., Laucht, M., & 
Schmidt, M. H. (2007a). Predictors of hyperkinetic 
disorder – early recognition in childhood. 
Zeitschrift für Kinder- und Jugendpsychiatrie und 
Psychotherapie, 35, 127-136.   
Esser, G., Fischer, S., Wyschkon, A., Laucht, M., & 
Schmidt, M. H., (2007b). Precusors of hyperactive 
disorders: Potential early diagnosis in infants? 
Zeitschrift für Kinder- und Jugendpsychiatrie und 
Psychotherapie, 35, 179-1488.  
Eyberg, S.M.,Boggs, S.R., & Algina, J. (1995). Parent-
child interaction therapy – a psychosocial model for 
the treatment of young-children with conduct problem 
behaviors and their families. Psychopharmacology 
Bulletin, 31, 83–91. 
Fallgatter, A. J., Ehlis, A. C., Rosler, M., Strik, W. 
K., Blocher, D., & Herrmann, M. J. (2005). 
Diminished prefrontal brain function in adults with 
psychopathology in childhood related to attention 
deficit hyperactivity disorder. Psychiatry Research-
Neuroimaging, 138, 157-169. 
Fantuzzo, J., Grim, S., Mordell, M., McDermott, P., 
Miller, L. & Coolahan, K. (2001). A multivariate 
analysis of the revised Conners’ Teacher Rating 
Scale with low-income, urban preschool children.  
Journal of Abnormal Child Psychology, 29, 141-152. 
Faraone, S.V., Perlis, R.H., Doyle, A.E., Smoller, J.W., 
Goralnick, J.J., Holmgren, M.A., et al. (2005). 
Molecular genetics of attention-
deficit/hyperactivity disorder. Biological 
Psychiatry, 57, 1313-1323. 
Fava, G. A., & Sonino, N. (2008). The biopsychosocial 
model thirty years later. Psychotherapy and 
Psychosomatics, 77, 1-2. 
Forehand, R. L. & McMahon, R. J. (1981). Helping the 
Noncompliant Child: A Clinician's Guide to Parent 
Training. New York: The Guilford Press. 
Frazier, T. W., Youngstrom, E. A., & Naugle, R. I. 
(2007). The latent structure of attention-
deficit/hyperactivity disorder in a clinic-referred 
sample. Neuropsychology, 21, 45-64.  
Gadow, K. D., Nolan, E. E., Sprafkin, J., & Schwartz, J. 
(2002). Tics and psychiatric comorbidity in children 
and adolescents. Developmental Medicine and Child 
Neurology, 44, 330-338. 
Gale, C. R., Robinson, S. M., Godfrey, K. M., Law, C. 
M., Schlotz, W. & O’Callaghan, F. J. (2008). Oily 
fish intake during pregnancy – association with 
lower hyperactivity but not with higher full-scale 
IQ in offspring. Journal of Child Psychology and 
Psychiatry, 49, 1061-1068.  
Gathje, R. A., Lewandowski, L. J., & Gordon, M. (2008). 
The role of impairment in the diagnosis of ADHD. 
Journal of Attention Disorders, 11, 529-537.  
Geurts, H. M., Vertie, S., Oosterlaan, J., Roeyers, H., 
& Sergeant, J. A. (2004). How specific are executive 
functioning deficits in attention deficit 
hyperactivity disorder and autism?  Journal οf Child 
Psychology αnd Psychiatry, 45, 836-854. 
Ghuman, J. K., Arnold, L. E., & Anthony, B. J. (2008). 
Psychopharmacological and Other Treatments in 
Preschool Children with Attention-
Deficit/Hyperactivity Disorder: Current Evidence and 
Practice. Journal of Child and Adolescent 
Psychopharmacology, 18, 413-447. 
Ghuman, J. K., Riddle, M. A., Vitiello, B., Greenhill, 
L. L., Chuang, S. Z., Wigal, S. B., et al. (2007). 
Comorbidity moderates response to methylphenidate in 
the Preschoolers with attention-
deficit/hyperactivity disorder Treatment Study 
(PATS). Journal of Child and Adolescent 
Psychopharmacology, 17, 563-579. 
Gill, A., Hyde, L. W., Shaw, D. S., Dishion, T. J., & 
Wilson, M. N. (2008). The Family Check-Up in Early 
Childhood: A Case Study of Intervention Process and 
Change. Journal of Clinical Child and Adolescent 
Psychology, 37, 893-904. 
Gjone, H., Stevenson, J. & Sundet, J. M. (1996). Genetic 
influence on parent-reported attention-related 
problems in a Norwegian general population twin 
sample. Journal of the American Academy of Child and 
Adolescent Psychiatry, 35, 588-596.  
Gonon, F. (2009). The dopaminergic hypothesis of 
attention-deficit/hyperactivity disorder needs re-
examining. Trends in Neuroscience, 32, 2-8.  
Graham, J., & Coghill, D. (2008). Adverse effects of 
pharmacotherapies for attention-deficit 
hyperactivity disorder - Epidemiology, prevention 
and management. CNS Drugs, 22, 213-237.  
Greenhill, L. L., Posner, K., Vaughan, B. S., & 
Kratochvil, C. J. (2008). Attention deficit 
hyperactivity disorder in preschool children. Child 
and Adolescent Psychiatry Clinics of North America, 
17, 347-366.  
Greenhill, L., Kollins, S., Abikoff, H., McCracken, J., 
Riddle, M., Swanson, J., et al. (2006). Efficacy and 
safety of immediate-release methylphenidate 
treatment for preschoolers with ADHD. Journal of the 
American Academy of Child and Adolescent Psychiatry, 
45, 1284-1293. 
Grund, T., Lehman, K., Bock, N., Rothenberger, A., & 
Teuchert-Noodt, G. (2006). Influence of 
methylphenidate on brain development--an update of 
recent animal experiments. Behavioral Brain 
Functions, 2, 2.  
Halperin, J. M., & Schulz, K. P. (2006). Revisiting the 
role of the prefrontal cortex in the pathopysiology 
of attention-deficit/hyperactivity disorder. 
Psychological Bulletin, 132, 560-581.  
Halperin, J. M., Trampush, J. W., Miller, C. J., Marks, 
D. J., & Newcorn, J. H. (2008). Neuropsychological 
outcome in adolescents/young adults with childhood 
ADHD: profiles of persisters, remitters and 
controls. Journal of Child Psychology and 
Psychiatry, 49, 958-966.  
Hardy, K. K., Kollins, S. H., Murray, D. W., Riddle, M. 
A., Greenhill, L., Cunningham, C., et al. (2007). 
Factor structure of parent- and teacher-rated 
attention-deficit/hyperactivity disorder symptoms in 
the Preschoolers with Attention-
Deficit/Hyperactivity Disorder Treatment Study 
(PATS). Journal of Child and Adolescent 
Psychopharmacology, 17, 621-633.  
Hartman, R. R., Stage, S. A., & Webster-Stratton, C. 
(2003). A growth curve analysis of parent training 
outcomes: Examining the influence of child risk 
factors (inattention, impulsivity, and hyperactivity 
problems), parental and family risk factors. Journal 
of Child Psychology & Psychiatry, 44, 388-398. 
Harvey, E. A., Friedman-Weieneth, J. L., Goldstein, L. 
H., Sherman, A. H., (2007). Examining subtypes of 
behavior problems among 3-year-old children, part I: 
Investigating validity of subtypes and biological 
risk-factors. Journal of Abnormal Child Psychology, 
35, 97-110.  
Haslam, N., Williams, B., Prior, M., Haslam, R., Graetz, 
B., & Sawyer, M. (2006). The latent structure of 
attention-deficit/hyperactivity disorder: a 
taxometric analysis. Australian and New Zealand 
Journal of Psychiatry, 40, 639-647.  
Healey, D. M., Miller, C. J., Castelli, K. L., Marks, D. 
J., & Halperin, J. M. (2008). The impact of 
impairment criteria on the rates of ADHD diagnoses 
in preschoolers. Journal of Abnormal Child 
Psychology, 36, 771-778.  
Hebebrand, J., Dempfle, A., Saar, K., Thiele, H., 
Herpertz-Dahlmann, B., Linder, M., et al. (2006). A 
genome-wide scan for attention-deficit/hyperactivity 
disorder in 155 German sib-pairs. Molecular 
Psychiatry, 11, 196-205.  
Heinrich, H., Gevensleben, H., & Strehl, U. (2007). 
Neurofeedback - train your brain to train behaviour. 
Journal of Child Psychology and Psychiatry, 48, 3-
16.  
Helzer, J. E., Kraemer, H. C., & Krueger, R. F. (2006). 
The feasibility and need for dimensional psychiatric 
diagnoses. Psychological Medicine, 36, 1671–1680. 
Hernandez-Lloreda, M. V., & Colmenares, F. (2005). 
Regularities and diversity in developmental pathways: 
Mother-infant relationships in hamadryas baboons. 
Developmental Psychobiology, 47, 297-317.  
Hill, L. G., Lochman, J. E., Coie, J. D., Greenberg, M. 
T., & Conduct Problems Prevention Research Group 
(2004). Effectiveness of early screening for 
externalizing problems: Issues of screening accuracy 
and utility. Journal of Consulting and Clinical 
Psychology, 72, 809-820. 
Hinshaw, S. P., Klein, R. G., & Abikoff, H. (1998). 
Childhood attention-deficit hyperactivity disorder: 
Nonpharmacologic and combination approaches. In P.E. 
Nathan & J.M. Gorman (Eds.), A Guide to Treatments 
that Work (pp. 27-41). New York: Oxford University 
Press. 
Hinshaw, S. P., Klein, R. G., & Abikoff, H. (2002). 
Childhood attention-deficit hyperactivity disorder: 
Nonpharmacologic treatments and their combination 
with medication. In P.E. Nathan & J.M. Gorman 
(Eds.), A Guide to Treatments that Work (pp. 1-23). 
New York: Oxford University Press. 
Jacobvitz, D., & Sroufe, A. (1987). The early caregiver-
child relationship and attention deficit disorder 
with hyperactivity in kindergarten: A prospective 
study. Child Development, 58, 1496-1504. 
Jensen, P. S., Arnold, L. E., Richters, J. E., Severe, 
J. B., Vereen, D., Vitiello, B., et al. (1999). A 
14-month randomized clinical trial of treatment 
strategies for attention-deficit/hyperactivity 
disorder. Archives of General Psychiatry, 56, 1073-
1086.  
Jensen, P. S., Arnold, L. E., Swanson, J. M., Vitiello, 
B., Abikoff, H. B., Greenhill, L. L., et al. (2007). 
3-year follow-up of the NIMH MTA study. Journal of 
the American Academy of Child and Adolescent 
Psychiatry, 46, 989-1002.  
Jester, J. M., Nigg, J. T., Adams, K., Fitzgerald, H. 
E., Puttler, L. I., Wong, M. M., & Zucker, R. A. 
(2005). Inattention/hyperactivity and aggression 
from early childhood to adolescence: Heterogeneity 
of trajectories and differential influence of family 
environment characteristics. Development and 
Psychopathology, 17, 99-125.  
Jones, K., Daley, D., Hutchings, J., Bywater, T., & 
Eames, C. (2008). Efficacy of the Incredible Years 
Programme as an early intervention for children with 
conduct problems and ADHD: long-term follow-up. 
Child: Care, Health and Development, 34, 380-390.  
Kahn, R. S., Khoury, J., Nichols, W. C., & Lanphear, B. 
P. (2003). Role of dopamine transporter genotype and 
maternal prenatal smoking in childhood hyperactive-
impulsive, inattentive, and oppositional behaviours. 
Journal of Pediatrics, 143, 104-110. 
Karabekiroglu, K., Yazgan, Y. M., & Dedeoglu, C. (2008). 
Can we predict short-term side effects of 
methylphenidate immediate-release? International 
Journal of Psychiatry in Clinical Practice, 12, 48-
54.  
Keenan, K & Wakschlag, L.S. (2000). More than the 
terrible twos: The nature and severity of behavior 
problems in clinic-referred preschool children. 
Journal of Abnormal Child Psychology, 28, 33–46. 
Kern, L., DuPaul, G. J., Volpe, R. J., Sokol, N. G., 
Lutz, J. G., Arbolino, L. A., et al. (2007). 
Multisetting assessment-based intervention for young 
children at risk for attention deficit hyperactivity 
disorder: Initial effects on academic and behavioral 
functioning. School Psychology Review, 36, 237-255. 
Kerns, K., Eso, K., & Thomson, J. (1999). Investigation 
of a direct intervention for improving attention in 
young children with ADHD. Developmental 
Neuropsychology, 16, 273-295. 
Kerruish, N. J., & Robertson, S. P. (2005). Newborn 
screening: new developments, new dilemmas. Journal 
of Medical Ethics, 31, 393-398.
Kieling, C., Goncalves, R. R. F., Tannock, R., & 
Castellanos, F. X. (2008). Neurobiology of attention 
deficit hyperactivity disorder. Child and Adolescent 
Psychiatric Clinics of North America, 17, 285-+.  
Klingberg, T., Fernell, E., Olesen, P. J., Johnson, M., 
Gustafsson, P., Dahlstrom, K., et al. (2005). 
Computerized training of working memory in children 
with ADHD -a randomized, controlled trial. Journal 
of the American Academy of Child & Adolescent 
Psychiatry, 44, 177-186. 
Kollins, S. H., & Greenhill, L. (2006). Evidence base 
for the use of stimulant medication in preschool 
children with ADHD. Infants and Young Children, 19, 
132-141. 
Konofal, E., Lecendreux, M., Arnulf, I., & Mouren, M.C. 
(2004). Iron deficiency in children with attention-
deficit/hyperactivity disorder. Archives of 
Pediatrics and Adolescent Medicine, 158, 1113-1115. 
Kratochvil, C. J., Vaughan, B. S., Mayfield-Jorgensen, 
M. L., March, J. S., Kollins, S. H., Murray, D. W., 
et al. (2007). A pilot study of atomexine in young 
children with attention-deficit/hyperactivity 
disorder. Journal of Child and Adolescent 
Psychopharmacology, 17, 175-185. 
Lahey, B. B., Pelham, W. E., Loney, J., Kipp, H., 
Erhardt, A., Lee, S. S., et al. (2004). Three-year 
predictive validity of DSM-IV attention deficit 
hyperactivity disorder in children diagnosed at 4-6 
years of age. American Journal of Psychiatry, 161, 
2014-2020.  
Lahey, B. B., Pelham, W. E., Loney, J., Lee, S. S., & 
Willcutt, E. (2005). Instability of DSM-IV subtypes 
of ADHD from preschool through elementary school. 
Archives of General Psychiatry, 62, 896-902.  
Lahey, B. B., Rathouz, P. J., Van Hulle, C., Urbano, R. 
C., Krueger, R. F., Applegate, B., et al. (2008). 
Testing structural models of DSM-IV symptoms of 
common forms of child and adolescent 
psychopathology. Journal of Abnormal Child 
Psychology, 36, 187-206.  
Lasky-Su, J., Anney, R., Neale, B. M., Franke, B., Zhou, 
K., Maller, J. B., et al. (2008). Genome-wide 
Association Scan of Attention Deficit Hyperactivity 
Disorder. American Journal of Medical Genetics Part 
B: Neuropsychiatric Genetics, Epub ahead of print. 
Lavigne, J.V., Arend, R., Rosenbaum, D., Binns, H.J., 
Christoffel, K.K & Gibbons, R.D. (1998). Psychiatric 
disorders with onset in the preschool years: I. 
Stability of diagnoses. Journal of the American 
Academy of Child and Adolescent Psychiatry, 37, 
1246-1254.  
Leblanc, N., Boivin, M., Dionne, G., Brendgen, M., 
Vitaro, F., Tremblay, R. E., & Perusse, D. (2008). 
The development of hyperactive-impulsive behaviors 
during the preschool years: The predictive validity 
of parental assessments. Journal of Abnormal Child 
Psychology, 36, 977-987.  
Lee, S. S., Lahey, B. B., Owens, E. B., & Hinshaw, S. P. 
(2008). Few preschool boys and girls with ADHD are 
well-adjusted during adolescence. Journal of 
Abnormal Child Psychology, 36, 373-383.  
Leslie, L. K., Stallone, K. A., Weckerly, J., McDaniel, 
A. L., & Monn, A. (2006). Implementing ADHD 
guidelines in primary care: Does one size fit all? 
Journal of Health Care for the Poor and Underserved, 
17, 302-327.  
Leung, P. W., Luk, S. L., Ho, T. P., Taylor, E., Mak, F. 
L., & BaconShone, J. (1996). The diagnosis and 
prevalence of hyperactivity in Chinese schoolboys. 
British Journal of Psychiatry, 168, 486-496.  
Linares, T. J., Singer, L. T., Kirchner, H. L., Short, 
E. J., Min, M. O., Hussey, P., et al. (2006). Mental 
health outcomes of cocaine-exposed children at 6 
years of age. Journal of Pediatric Psychology, 31, 
85-97. 
Lou, H. C. (1996). Etiology and pathogenesis of 
attention-deficit Hyperactivity Disorder (ADHD): 
Significance of prematurity and perinatal hypoxic-
haemodynamic encephalopathy. Acta Paediatrica, 85, 
1266-1271.   
Lubar, J. F. (1997). Neocortical dynamics: Implications 
for understanding the role of neurofeedback and 
related techniques for the enhancement of attention. 
Applied Psychophysiology and Biofeedback. 22, 111-
126.  
Luciana, M. (2003). Cognitive development in children 
born preterm: Implications for theories of brain 
plasticity following early injury. Development and 
Psychopathology, 15, 1017-1047.  
Luman, M., Oosterlaan, J., & Sergeant, J. A. (2005). The 
impact of reinforcement contingencies on AD/HD: A 
review and theoretical appraisal. Clinical 
Psychology Review, 25, 183-213. 
Madras, B. K., Miller, G. M., & Fischman, A. I. (2005). 
The dopamine transporter and attention-
deficit/hyperactivity disorder. Biological 
Psychiatry, 57, 1397-1409. 
Madras, B. K., Miller, G. M., Fischman, A. J. (2002). 
The dopamine transporter: relevance to attention 
deficit hyperactivity disorder (ADHD). Behavioural 
Brain Research, 130, 57-63.  
Makris, N., Biederman, J., Valera, E. M., Bush, G., 
Kaiser, J., Kennedy, D. N., et al. (2007). Cortical 
thinning of the attention and executive function 
networks in adults with Attention-
Deficit/Hyperactivity disorder. Cerebral Cortex, 17, 
1364-1375.  
Maniadaki, K., Sonuga-Barke, E., Kakouros, E., & Karaba, 
R. (2007). Parental beliefs about the nature of ADHD 
behaviours and their relationship to referral 
intentions in preschool children. Child Care Health 
and Development, 33, 188-195.  
Mannuzza, S., Klein, R. G., Abikoff, H., & Moulton, J. 
L. (2004). Significance of childhood conduct 
problems to later development of conduct disorder 
among children with ADHD: A prospective follow-up 
study. Journal of Abnormal child Psychology, 32, 
565-573.  
Marakovitz, S. E. & Campbell, S. B. (1998). Inattention, 
impulsivity and hyperactivity from preschool to 
school age: performance of hard-to-manage boys on 
laboratory measures. Journal of Child Psychology and 
Psychiatry and Allied Disciplines, 39, 841-851.  
Marco, R., Miranda, A., Schlotz, W., Melia, A., 
Mulligan, A., Müller, U., et al. (2009). Delay and 
reward choice in ADHD: An experimental test of the 
role of delay aversion. Neuropsychology. 
Mariussen, E., & Fonnum, F. (2006). Neurochernical 
targets and behavioral effects of organohalogen 
compounds: An update. Critical Reviews in 
Toxicology, 36, 253-289. 
Marks, D. J., Berwid, O. G., Santra, A., Kera, E. C., 
Cryulnik, S. E., & Halperin, J. M. (2005). 
Neuropsychological correlates of ADHD symptoms in 
preschoolers. Neuropsychology, 19, 446-455.  
Mathiesen, K.S & Sanson, A. (2000). Dimensions of early 
childhood behavior problems: Stability and 
predictors of change from 18 to 30 months. Journal 
of Abnormal Child Psychology, 28, 15–31. 
McCann, D., Barrett, A., Cooper, A., Crumpler, D., 
Dalen, L., Grimshaw, K., et al. (2007). Food 
additives and hyperactive behaviour in 3 and 8/9 
year old children in the community. The Lancet, 370, 
1560-1567.  
McGoey, K. E., Eckert, T. L., & Paul, G. J. (2002). 
Early intervention for preschool-age children with 
ADHD: A literature review. Journal of Emotional and 
Behavioral Disorders, 10, 14-28.  
McNab, F., Varrone, A., Farde, L., Jucaite, A., 
Bystritsky, P., Forssberg, H., et al. (2009). 
Changes in Cortical Dopamine D1 Receptor Binding 
Associated with Cognitive Training. Science, 323, 
800-802.  
Michel, J. A., & Mateer, C. A. (2006). Attention 
rehabilitation following stroke and traumatic brain 
injury. A review. Eura Medicophys, 42, 59-67.  
Miklowitz, D. J., & Cicchetti, D. (2006). Toward a life 
span developmental psychopathology perspective on 
bipolar disorder. Development and Psychopathology, 
18, 935-938.  
Mill, J., & Petronis, A. (2008). Pre- and peri-natal 
environmental risks for attention-deficit 
hyperactivity disorder (ADHD): the potential role of 
epigenetic processes in mediating susceptibility. 
Journal of Child Psychology and Psychiatry, 49, 
1020-1030.  
Moffitt, T.E. (1993). The neuropsychology of Conduct 
Disorder. Development and Psychopathology, 5, 135 – 
151. 
Molina, B.S.G., Hinshaw, S.P., Swanson, J.M., Arnold, L. 
E., Vitiello, B., Jensen, P.S., Epstein, J.N., Hoza, 
B., Hechtman, L.,  Abikoff, H.B., Elliott, G.R., 
Greenhill, L.L., Newcorn, J.H., Wells, K.C., Wigal, 
T., Gibbons, R.D., Hur, K., Houck, P.R., and the MTA 
Cooperative Group. (2009). MTA at 8 Years: 
Prospective Follow-up of Children Treated for 
Combined-Type ADHD in a Multisite Study.  Journal of 
the American Academy of Child and Adolescent 
Psychiatry, 48, 484-500. 
Morrell, J., & Murray, L. (2003). Parenting and the 
development of conduct disorder and hyperactive 
symptoms in childhood: a prospective longitudinal 
study from 2 months to 8 years. Journal of Child 
Psychology and Psychiatry, 44, 489-508.  
Neef, N. A., Bicard, D. F. & Endo, S. (2001). Assessment 
of impulsivity and the development of self-control 
in students with attention deficit hyperactivity 
disorder. Journal of Applied Behavior Analysis, 34, 
397-408.  
Neville, H. J. (2006). Different profiles of plasticity 
within human cognition. In Y. Munakata, M. H. 
Johnson (Eds.). Processes of change in brain and 
cognitive development: Attention and Performance XXI 
(pp. 287-314). Attention and Performance.  
Nigg, J. T., Knottnerus, G. M., Martel, M. M., Nikolas, M., 
Cavanagh, K., Karmaus, W., & Rappley, M. D. (2008). Low 
blood lead levels associated with clinically diagnosed 
attention-deficit/hyperactivity disorder and mediated by 
weak cognitive control. Biological Psychiatry, 63, 325-
331.  
Nigg, J. T., Willcutt, E. G., Doyle, A. E., & Sonuga-
Barke, E. J. S. (2005). Causal heterogeneity in 
attention-deficit/hyperactivity disorder: Do we need 
neuropsychologically impaired subtypes? Biological 
Psychiatry, 57, 1224-1230. 
Nigg, J.T. (2006). What causes ADHD? Understanding what 
goes wrong and why. New York: The Guilford Press, 
422.  
O’Connell, R. G., Bellgrove, M. A., Dockree, P. M., Lau, 
A., Fitzgerald, M., & Roberson, I. H. (2008). Self-
Alert Training: Volitional modulation of autonomic 
arousal improves sustained attention. 
Neuropsychologia, 46, 1379-1390.  
O’Connor, T. G., Heron, J., Golding, J., & Glover, V. 
(2003). Maternal antenatal anxiety and 
behavioural/emotional problems in children: a test 
of a programming hypothesis. Journal of Child 
Psychology and Psychiatry, 44, 1025-1036.  
Oades, R. D., Sadile, A. G., Sagvolden, T., Viggiano, 
D., Zuddas, A., Devoto, P., et al. (2005). The 
control of responsiveness in ADHD by catecholamines: 
evidence for dopaminergic, noradrenergic and 
interactive roles. Developmental Science, 8, 122-
131. 
Olijslagers, J. E., Werkman, T. R., McCreary, A. C., 
Kruse, C. G., & Wadman, W. J. (2006). Modulation of 
midbrain dopamine neurotransmission by serotonin, a 
versatile interaction between neurotransmitters and 
significance for antipsychotic drug action. Current 
Neuropharmacology, 4, 59-68.  
Ostrander, R. & Herman, K. C. (2006). Potential 
cognitive, parenting, and developmental mediators of 
the relationship between ADHD and depression. 
Journal of Consulting and Clinical Psychology, 74, 
89-98. 
Pavuluri, M.N. & Luk, S.L. (1998). Recognition and 
classification of psychopathology in preschool 
children. Australian & New Zealand Journal of 
Psychiatry, 32, 642-649.  
Pelham, W. E. Jr., & Fabiano, G. A. (2008). Evidence-
based psychosocial treatments for attention-
deficit/hyperactivity disorder. Journal of Clinical 
Child and Adolescent Psychology, 37, 184-214. 
Perwien, A., Hall, J., Swensen, A., & Swindle, R. 
(2004). Stimulant treatment patterns and compliance 
in children and adults with newly treated attention-
deficit/hyperactivity disorder. Journal of Managed 
Care Pharmacy, 10, 122-129. 
Pisterman, S., Firestone, P., McGrath, P., Goodman, J. 
T., Webster, I., Mallory, R., & Goffin, B. (1992). 
The role of parent training in treatment of 
preschoolers with ADDH. American Journal of 
Orthopsychiatry, 62, 397-408. 
Pisterman, S., McGrath, P., Firestone, P., Goodman, J. 
T., Webster, I., & Mallory, R. (1989). Outcome of 
Parent-Mediated Treatment of Preschoolers with 
Attention Deficit Disorder with Hyperactivity. 
Journal of Consulting & Clinical Psychology, 57, 
628-635. 
Pliszka, S. R. (2005). The neuropsychopharmacology of 
attention-deficit/hyperactivity disorder. Biological 
Psychiatry, 57, 1385-1390.  
Polderman, T. J. C., Derks, E. M., Hudziak, J. J., 
Verhulst, F. C., Posthuma, D., & Boomsma, D. I. 
(2007). Across the continuum of attention skills: a 
twin study of the SWAN ADHD rating scales. Journal 
of Child Psychology and Psychiatry, 48, 1080-1087.  
Posner, K., Melvin, G. A., Murray, D. W., Gugga, S. S., 
Fisher, P., Skrobala, A., et al. (2007). Clinical 
presentation of attention-deficit/hyperactivity 
disorder in preschool children: The preschoolers 
with attention-deficit/hyperactivity treatment study 
(PATS). Journal of Child and Adolescent 
Psychopharmacology, 17, 547-562.  
Rapee, R. M. (2008). Prevention of mental disorders: Promises, 
limitations, and barriers. Cognitive and Behavioral 
Practice, 15, 47-52.  
Rapoport, J. L., & Gogtay, N. (2008). Brain 
neuroplasticity in  healthy, hyperactive and 
psychotic children: Insights from neuroimaging. 
Neuropsychopharmacology, 33, 181-197.  
Reif, A., Rosler, M., Freitag, C. M., Schneider, M., 
Eujen, A., Kissling, C., et al. (2007). Nature and 
nurture predispose to violent behavior: Serotonergic 
genes and adverse childhood environment. 
Neuropsychopharmacology, 32, 2375-2383.  
Rende, R. D. (1993). Longitudinal relation between 
temperament traits and behavioral syndromes in 
middle childhood. Journal of the American Academy of 
Child and Adolescent Psychiatry, 32, 287-290. 
Retz, W. G., Freitag, C. M., Retz-Junginger, P., 
Wenzler, D., Schneider, M., Kissling, C., et al. 
(2008). A functional serotonin transporter promoter 
gene polymorphism increases ADHD symptoms in 
delinquents: Interaction with adverse childhood 
environment. Psychiatry Research, 158, 123-131.  
Rhodes, S. M., Coghill, D. R., & Matthews, K. (2004). 
Methylphenidate restores visual memory, but not 
working memory function in attention deficit-
hyperkinetic disorder. Psychopharmacology, 175, 319-
330. 
Richardson, A. J., & Montgomery, P. (2005). The Oxford-
Durham study: A randomized, controlled trial of 
dietary supplementation with fatty acids in children 
with developmental coordination disorder. 
Pediatrics, 115, 1360-1366.  
Rietveld, M. J. H., Hudziak, J. J., Bartels, M., van 
Beijsterveldt, C. E. M., & Boomsma, D. I. (2003). 
Heritability of attention problems in children: I. 
Cross-sectional results from a study of twins, age 
3-12 years. American Journal of Medical Genetics 
Part B-Neuropsychiatric Genetics, 117B, 102-113.  
Rodriguez, A., & Bohlin, G. (2005). Are maternal smoking 
and stress during pregnancy related to ADHD symptoms 
in children? Journal of Child Psychology and 
Psychiatry, 46, 246-254. 
Rubia, K., Overmeyer, S., Taylor, E., Brammer, M., 
Williams, S. C. R., Simmons, A., et al. (1999). 
Hypofrontality in attention deficit hyperactivity 
disorder during higher-order motor control: A study 
with functional MRI. American Journal of Psychiatry, 
156, 891-896.  
Rueda, M. R., Rothbart, M. K., McCandliss, B. D., 
Saccomanno, L., & Posner, M. I. (2005). Training, 
maturation, and genetic influences on the 
development of executive attention. Proceedings of 
the National Academy of Sciences of the United 
States of America, 102, 14931-14936.  
Rutter, M., Beckett, C., Castle, J., Colvert, E., 
Kreppner, J., Mehta, M., et al. (2007). Effects of 
profound early institutional deprivation: An 
overview of findings from a UK longitudinal study of 
Romanian adoptees. European Journal of Developmental 
Psychology, 4, 332-350. 
Sagvolden, T., Johansen, E. B., Aase, H., & Russell, V. 
A. (2005). A dynamic developmental theory of 
attention-deficit/hyperactivity disorder (ADHD) 
predominantly hyperactive/impulsive and combined 
subtypes.  he behavioral and brain science, 28, 397-
419. 
Sanchez, R. J., Crismon, M. L., Barner, J. C., 
Bettinger, T., & Wilson, J. P. (2005) Assessment of 
adherence measures with different stimulants among 
children and adolescents. Pharmacotherapy, 25, 909-
917. 
Sanson, A., Smart, D., Prior, M., & Oberkland, F. 
(1993). Precursors of hyperactivity and aggression. 
Journal of the American Academy of Child and 
Adolescent Psychiatry, 32, 1207-1216. 
Scheres, A., Dijkstra, M., Ainslie, E., Balkan, J., 
Reynolds, B., Sonuga-Barke, E., et al. (2006). 
Temporal and probabilistic discounting of rewards in 
children and adolescents: effects of age and ADHD 
symptoms. Neuropsychologia, 44, 2092-2103. 
Schmidt, S., & Peterman, F. (2008). Developmental 
Psychopathology of ADHD. Zeitschrift fur Psychiatrie 
Psychologie und Psychotherapie, 56, 265-274.  
Schulz, K. P., Newcorn, J. H., Fan, J., Tang, C. Y., & 
Halperin, J. M. (2005a). Brain activation gradients 
in ventrolateral prefrontal cortex related to 
persistence of ADHD in adolescent boys. Journal of 
the American Academy of Child and Adolescent 
Psychiatry, 44, 47-54. 
Schulz, K. P., Tang, C. Y., Fan, J., Marks, D. J., 
Newcorn, J. H., Cheung, A. M., et al. (2005b). 
Differential prefrontal cortex activation during 
inhibitory control in adolescents with and without 
childhood attention-deficit/hyperactivity disorder. 
Neuropsychology, 19, 390-402. 
Seidman, L. J. (2006). Neuropsychological functioning in 
people with ADHD across the lifespan. Clinical 
Psychology Review, 26, 466-485.  
Seipp, C. M., & Johnston, C. (2005). Mother-son 
interactions in families of boys with attention-
deficit/hyperactivity disorder with and without 
oppositional behavior. Journal of Abnormal Child 
Psychology, 33, 87-98. 
Sergeant, J. A. (2005). Modeling attention-
deficit/hyperactivity disorder: A critical appraisal 
of the cognitive-energetic model. Biological 
Psychiatry, 57, 1248-1255. 
Serketich, W. J., & Dumas, J. E. (1996). The 
effectiveness of behavioral parent training to 
modify antisocial behavior in children: A meta-
analysis. Behavior Therapy, 27, 171-186. 
Shalev, L., Tsal, Y., & Mevorach, C. (2007). 
Computerized progressive attentional training (CPAT) 
program: Effective direct intervention for children 
with ADHD. Child Neuropsychology, 13, 382-388.  
Shaw, D. S., Dishion, T. J., Supplee, L., Gardner, F., & 
Arnds, K. (2006). Randomized trial of a family-
centered approach to the prevention of early conduct 
problems: 2-year effects of the family check-up in 
early childhood. Journal of Consulting and Clinical 
Psychology, 74, 1-9.  
Shaw, P., Eckstrand, K., Sharp, W., Blumenthal, J., 
Lerch, J. P., Greenstein, D., et al. (2007). 
Attention-deficit/hyperactivity disorder is 
characterized by a delay in cortical maturation. 
Proceedings of the National Academy of Science, 104, 
19649-19654. 
Singh, I. (2008). SCIENCE AND SOCIETY Beyond polemics: 
science and ethics of ADHD. Nature Reviews 
Neuroscience, 9, 957-964.  
Smidts, D. P., & Osterlaan, J. (2007). How common are 
symptoms of ADHD in typically developing 
preschoolers? a study on prevalence rates and 
prenatal/demographic risk factors. Cortex, 43, 710-
171.  
Smith, A., Taylor, E., Rogers, J. W., Newman, S., & 
Rubia, K. (2002). Evidence for a pure time 
perception deficit in children with ADHD. Journal οf 
Child Psychology αnd Psychiatry, 43, 529-542. 
Smith, K. G., & Corkum, P. (2007). Systematic review of 
measures used to diagnose attention-
deficit/hyperactivity disorder in research on 
preschool children. Topics in Early Childhood 
Special Education, 27, 164-173.  
Sohlberg, M. M., & Mateer, C. A. (2001). Attention and 
managing attentional problems. – Adapting 
rehabilitation techniques to adults with ADHD. Adult 
Attention Deficit Disorder, Annals of the New York 
Academy of Sciences, 931, 359-375.  
Solanto, M. V., Abikoff, H., Sonuga-Barke, E., Schachar, 
R., Logan, G. D., Wigal, T., et al., (2001). The 
ecological validity of delay aversion and response 
inhibition as measures of impulsivity in AD/HD: a 
supplement to the NIMH multimodal treatment study of 
AD/HD. Journal of Abnormal Child Psychology, 29, 
215-228. 
Sonuga-Barke, E. J. S., Minocha, K., Taylor, E., & 
Sandberg, S. (1993). Inter ethnic bias in teachers’ 
ratings of childhood hyperactivity. British Journal 
of Developmental Psychology, 11, 187-200. 
Sonuga-Barke, E. J. S., Stevenson, J., Thompson, M., 
Viney, D. (1997). Patterns of behaviour problems 
among pre-school children. Psychological Medicine, 
7, 909-918. 
Sonuga-Barke, E. J. S. (1998). Categorical model in 
child psychopathology; a conceptual and empirical 
analysis. Journal of Child Psychology & Psychiatry, 
9, 115-133. 
Sonuga-Barke, E. J. (2003). The dual pathway model of 
AD/HD: an elaboration of neuro-developmental 
characteristics. Neuroscience and Biobehavioural 
Reviews, 27, 593-604. 
Sonuga-Barke, E. J. S., Daley, D., Thompson, M., & 
Swanson, J. (2003a). Preschool ADHD: exploring 
uncertainties in diagnostic validity and utility, 
and treatment efficacy and safety. Expert Reviews in 
Neuro-therapeutics, 3, 465-476. 
Sonuga-Barke E. J. S., Dalen, L., Remington, R. E. R. 
(2003b). Do delay aversion and inhibitory deficits 
make distinct contributions to pre-school AD/HD. 
Journal of the American Academy of Child & 
Adolescent Psychiatry, 42, 1335-1342.  
Sonuga-Barke, E. J.S. (2004). On the reorganisation of 
incentive structure to promote delay tolerance: a 
therapeutic possibility for AD/HD? Neural 
Plasticity: Special Issue: Clinical, Experimental 
and Modeling Studies in ADHD, 11, 23-28. 
Sonuga-Barke, E. J. (2005). Causal models of Attention-
Deficit/Hyperactivity Disorder: from common simple 
deficits to multiple developmental pathways. 
Biological Psychiatry, 57(11), 1231-1238. 
Sonuga-Barke, E. J. S., Auerbach, J., Campbell, S. B., 
Daley, D., & Thompson, M. (2005). Varieties of 
preschool hyperactivity: multiple pathways from risk 
to disorder. Developmental Science, 8, 141-150.  
Sonuga-Barke, E. J. S., Castellanos, F. X. (2005). A 
common core dysfunction in attention-
deficit/hyperactivity disorder: A scientific red 
herring? Behavioral and Brain Sciences 28, 443-444. 
Sonuga-Barke, E. J. S., Thompson, M., Abikoff, H., 
Klein, R., & Brotman, L. M. (2006). Non-
pharmacological interventions for preschool ADHD: 
The case for specialized parent training. Infants 
and Young Children, 19, 142-153.  
Sonuga-Barke, E. J. S., & Rubia, K. (2008). Inattentive 
and overactive children with histories of profound 
institutional deprivation compared to standard ADHD 
cases: A brief report. Child Care Health & 
Development, 34, 596-602.  
Sonuga-Barke, E. J., Sergeant, J., Nigg, J., & Willcutt, 
E. (2008a). Executive dysfunction and delay aversion 
in ADHD: Nosological and diagnostic implications. 
Child and Adolescent Psychiatric Clinics of North 
America, 17, 367-384. 
Sonuga-Barke, E., Beckett, C., Kreppner, J., Castle, J., 
Colvert, E., Stevens, S., et al. (2008b). Is sub-
nutrition necessary for a poor outcome following 
early institutional deprivation? Developmental 
Medicine and Child Neurology, 50, 664-671. 
Sonuga-Barke, E. J. S., Lasky-Su, J., Neale, B. M., 
Oades, R., Chen, W., Franke, B., et al. (2008c). 
Does parental expressed emotion moderate genetic 
effects in ADHD? An exploration using a genome wide 
association scan. American Journal of Medical 
Genetics, 147B, 1359-1368. 
Sonuga-Barke, E. J. S. (2009). Attention 
deficit/hyperactivity disorder: Towards a 
development synthesis. In P. Zelazo (Ed.) Oxford 
Handbook of Developmental Psychology. New York: 
Oxford University Press.  
Sonuga-Barke, E. J. S., Wiersema, J. R., Van Der Meere, J. J., 
& Roeyers H. (in press). Context dependent-dynamic models 
of attention deficit/hyperactivity disorder: 
differentiating common and unique elements of the state 
regulation deficit and delay aversion models. 
Neuropsychological Review.  
Speltz, M., McClellan,J., DeKlyen, M. & Jones, K.(1999). 
Preschool boys with oppositional defiant disorder: 
Clinical presentation and diagnostic change. Journal 
of the American Academy of Child & Adolescent 
Psychiatry, 38, 838-845. 
Spencer, T. J., Biederman, J., Madras, B. K., Dougherty, 
D. D., Bonab, A. A., Livni, E., et al. (2007). 
Further evidence of dopamine transporter 
dysregulation in ADHD: a controlled PET imaging 
study using altropane. Biological Psychiatry, 62, 
1059-61.  
Stevens, S. E., Sonuga-Barke, E. J. S., Kreppner, J. M., 
Beckett, C., Castle, J., Colvert, E., et al. (2008). 
Inattention/overactivity following early severe 
institutional deprivation: Presentation and 
associations in early adolescence. Journal of 
Abnormal Child Psychology, 36, 385-398.  
Strayhorn, J. M. & Weidman, C. S. (1989). Reduction of 
attention deficit and internalizing symptoms in 
preschoolers through parent-child interaction 
training. Journal of the American Academy of Child & 
Adolescent Psychiatry, 28, 888-896. 
Ströhle, A., Stoy, M., Wrase, J., Schwarzer, S., 
Schlagenhauf, F., Huss, M., et al. (2008). Reward 
anticipation and outcomes in adult males with 
attention-deficit/hyperactivity disorder. 
Neuroimage, 39, 966-972.  
Swanson, J. M., Elliott, G. R., Greenhill, L. L., Wigal, 
T., Arnold, L. E., Vitiello, B., et al. (2007a). 
Effects of stimulant medication on growth rates 
across 3 years in the MTA follow-up. Journal of the 
American Academy of child and Adolescent Psychiatry, 
46, 1015-1027.  
Swanson, J. M., Kinsbourne, M., Nigg, J., Lanphear, B., 
Stefanatos, G. A., Volkow, N., et al. (2007b). 
Etiologic subtypes of attention-
deficit/hyperactivity disorder: Brain imaging, 
molecular genetic and environmental factors and the 
dopamine hypothesis. Neuropsychology Review, 17, 39-
59.  
Swanson, J., Gupta, S., Lam, A., Shoulson, I., Lerner, 
M., Modi, N., et al. (2003). Development of a new 
once-a-day formulation of methylphenidate for the 
treatment of attention-deficit/hyperactivity 
disorder proof-of-concept and proof-of-product 
studies. Archives of General Psychiatry, 60, 204-
211.  
Tamm, L., Swanson, J. M., Lerner, M. A., Childress, C., 
Patterson, B., Lakes, K., et al. (2005). 
Intervention for preschoolers at risk for Attention-
Deficit/Hyperactivity Disorder (ADHD): Service 
before diagnosis. Clinical Neuroscience Research, 5, 
247-253.  
Taylor, E. (1999). Developmental neuropsychopathology of 
attention deficit and impulsiveness. Development and 
Psychopathology, 11, 607-628.  
Taylor, E. A., & Sonuga-Barke, E. J. S. (2008). 
Disorders of Attention and Activity. In: M. Rutter, 
D. Bishop, D. Pine, S. Scott, J. S. Stevenson, E. A. 
Taylor, A. Thapar (Eds.). Rutter’s Child & 
Adolescent Psychiatry (pp. 521-542). UK: Wiley-
Blackwell.  
Taylor, E., & Rogers, J. W. (2005). Practitioner review: 
Early adversity and developmental disorders. Journal 
of Child Psychology and Psychiatry 46, 451-467. 
Taylor, E., Chadwick, O., Heptinstall, E., & Danckaerts, 
M. (1996). Hyperactivity and conduct problems as 
risk factors for adolescent development. Journal of 
the American Academy of Child and Adolescent 
Psychiatry, 35, 1213-1226. 
Taylor, E., Dopfner, M., Sergeant, J., Asherson, P., 
Banaschewski, T., Buitelaar, J., et al. (2004). 
European clinical guidelines for hyperkinetic 
disorder - first upgrade. European Child & 
Adolescent Psychiatry, 13, 17-130.  
Taylor, T. K., & Biglan, A. (1998). Behavioral family 
interventions for improving child-rearing: A review 
of the literature for clinicians and policy makers. 
Clinical Child & Family Psychology Review, 1, 41-60. 
Thapar, A., Fowler, T., Rice, F., Scourfield, J., van 
den Bree, M., Thomas, H., et al. (2003). Maternal 
smoking during pregnancy and attention deficit 
hyperactivity disorder symptoms in offspring. 
American Journal of Psychiatry, 160, 1985-1989. 
Thapar, A., Harrington, R., Ross, K., & McGuffin, P. 
(2000). Does the definition of ADHD affect 
heritability? Journal of the American Academy of 
Child and Adolescent Psychiatry, 39, 1528-1536.  
Thapar, A., Langley, K., Asherson, P., & Gill, M. 
(2007). Gene-environment interplay in attention-
deficit hyperactivity disorder and the importance of 
a developmental perspective. British Journal of 
Psychiatry, 190, 1-3.   
Thapar, A., O'Donovan, M., & Owen, M. J. (2005). The 
genetics of attention deficit hyperactivity 
disorder. Human Molecular Genetics, 14, R275-R282.  
Thompson, M. J. J., Laver-Bradbury, C., Ayres, M., Le 
Poidevin, E., Mead, S., Dodds, C., et al. (2009). A 
small-scale randomised controlled trial of the 
revised New Forest Package for Prescholers with 
Attention Deficit Hyperactivity Disorder. European 
Child & Adolescent Psychiatry, online first.  
Thorell, L. B. (2007). Do delay aversion and executive 
function deficits make distinct contributions to the 
functional impact of ADHD symptoms? A study of early 
academic skill deficits. Journal of Child Psychology 
and Psychiatry, 48, 1061-1070.  
Thorell, L. B., Lindqvist, S., Nutley, S. B., Bohlin, 
G., & Klinberg, T. (2009). Training and transfer 
effects of executive functions in preschool 
children. Developmental Science, 12, 106-113.  
Timimi, S., & Taylor, E., (2004). ADHD is best 
understood as a cultural construct. British Journal 
of Psychiatry, 184, 8-9.  
Todd, R. D., & Neuman, R. J. (2007). Rapid publication - 
Gene-environment interactions in the development of 
combined type ADHD: Evidence for a synapse-based 
model. American Journal of Medical Genetics Part B-
Neuropsychiatric Genetics, 144b,  971-975. 
Toplak, M. E., Connors, L., Shuster, J., Knezevic, B., & 
Parks, S. (2008). Review of cognitive, cognitive-
behavioral, and neural-based interventions for 
Attention-Deficit/Hyperactivity Disorder (ADHD). 
Clinical Psychology Review, 28, 801-823.  
Toplak, M. E., Jain, U., & Tannock, R. (2005). Executive 
and motivational processes in adolescents with 
Attention-Deficit-Hyperactivity Disorder (ADHD). 
Behavioral and Brain Functions, 1, 8. 
Tripp, G., & Wickens, J. R. (2008). Dopamine transfer 
deficit: A neurobiological theory of altered 
reinforcement mechanisms in ADHD. Journal of Child 
Psychology and Psychiatry, 49, 691-704. 
Turner, D. C., Blackwell, A. D., Dowson, J. H., McLean, 
A., & Sahakian, B. J. (2005). Neurocognitive effects 
of methylphenidate in adult attention-
deficit/hyperactivity disorder. Psychopharmacology, 
178, 286-295. 
Vaidya, C. J., Bunge, S. A., Dudukovic, N. M., & 
Zalecki, C. A. (2005). Altered neural substrates of 
cognitive control in childhood ADHD: Evidence from 
functional magnetic resonance imaging. American 
Journal οf Psychiatry, 162, 1605-1613.  
Valera, E. M., Faraone, S. V., Murray, K. E., & Seidman, 
L. J. (2007). Meta-analysis of structural imaging 
findings in attention-deficit/hyperactivity 
disorder. Biological Psychiatry, 61, 1361-1369.   
Van den Bergh, F., Spronk, M., Ferreira, L., Bloemarts, 
E., Groenink, L., Olivier, B., et al. (2006). 
Relationship of delay aversion and response 
inhibition to extinction learning, aggression, and 
sexual behaviour. Behavioural Brain Research, 175, 
75-81. 
Vaughan, B. S., Wetzel, M. W., & Kratochvil, C. J. 
(2008). Beyond the ‘typical’ patient: Treating 
attention-deficit/ hyperactivity disorder in 
preschoolers and adults. International Review of 
Psychiatry, 20, 143-149.  
Vaurio, L., Riley, E. R., & Mattson, S. N. (2008). 
Differences in executive functioning in children 
with heavy prenatal alcohol exposure or attention-
deficit/hyperactivity disorder. Journal of the 
International Neuropsychological Society, 14, 119-
129. 
Vitiello, B., Abikoff, H. B., Chuang, S. Z., Kollins, S. 
H., McCracken, J. T., Riddle, M. A., et al. (2007). 
Effectiveness of methylphenidate in the 10-month 
continuation phase of the Preschoolers with ADHD 
Treatment Study (PATS). Journal of Child and 
Adolescent Psychopharmacology, 17, 593-603.  
Volkow, N. D., Wang, G. J., Newcorn, J., Fowler, J. S., 
Telang, F., Solanto, M. V., et al. (2007b). Brain 
dopamine transporter levels in treatment and drug 
naïve adults with ADHD. Neuroimage, 34, 1182-90.  
Volkow, N. D., Wang, G. J., Newcorn, J., Telang, F., 
Solanto, M. V., Fowler, J. S., et al. (2007a) 
Depressed dopamine activity in caudate and 
preliminary evidence of limbic involvement in adults 
with attention-deficit/hyperactivity disorder. 
Archives of General Psychiatry, 64, 932-940. 
Volkow, N. D., & Swanson, J. M. (2003). Variables that 
affect the clinical use and abuse of methylphenidate 
in the treatment of ADHD. American Journal of 
Psychiatry, 160, 1909-1918.  
Von Stauffenberg, C., & Campbell, S. B. (2007). 
Predicting the early developmental course of 
symptoms of attention deficit hyperactivity 
disorder. Journal of Applied Developmental 
Psychology, 28, 536-552.  
Vuksic, M., Rados, M., & Kostovic, I. (2008). Structural 
basis of development plasticity in the 
corticostriatal system. Collegium Antropologicum, 
32, 155-159.  
Wahlstedt, C., Thorell, L. B., & Bohlin, G. (2008). ADHD 
symptoms and executive function impairment: Early 
predictors of later behavioral problems. 
Developmental Neuropsychology, 33, 160-178.  
Webster-Stratton, C., Reid, M. J., & Hammond, M. (2001). 
Preventing conduct problems, promoting social 
competence: A parent and teacher training 
partnership in Head Start. Journal of Clinical Child 
Psychology, 30, 283-302. 
Weiss, M. D., Gadow, K., & Wasdell, M. B. (2006). 
Effectiveness outcomes in attention-
deficit/hyperactivity disorder. Journal of Clinical 
Psychiatry, 67, 38-45. 
Wiersema, R., Van der Meere, J., Antrop, I., & Roeyers, 
H. (2006). State regulation in adult ADHD: An event-
related potential study. Journal of Clinical and 
Experimental Neuropsychology, 28, 1113-1126. 
Wigal, T., Grenhill, L., Chuang, S., McGough, J., 
Vitiello, B., Skrobala, A., et al. (2006). Safety 
and tolerability of methylphenidate in preschool 
children with ADHD. Journal of the American Academy 
of Child and Adolescent Psychiatry, 45, 1294-1302. 
Willcutt, E. G., Doyle, A. E., Nigg, J. T., Faraone, S. 
V., & Pennington, B.F. (2005). Validity of the 
executive function theory of attention-
deficit/hyperactivity disorder: A meta-analytic 
review. Biological Psychiatry, 57, 1336-1346. 
Willcutt, E. G., Sonuga-Barke, E. J. S., Nigg, J. T., & 
Sergeant, J. A. (2008). Recent developments in 
neuropsychological models of childhood psychiatric 
disorders. In T. Banaschewski, L. A. Rohde (Eds.), 
Biological Child Psychiatry. Recent Trends and 
Developments. Advances in Biological Psychiatry. 
Basel: Karger, vol 24. 
Wolke, D., Rizzo, P., & Woods, S. (2002). Persistent 
infant crying and hyperactivity problems in middle 
childhood. Pediatrics, 109, 1054-1060. 
Yeh, M., Morley, K. I., & Hall, W. D. (2004). The policy 
and ethical implications of genetic research on 
attention deficit hyperactivity disorder. Australian 
and New Zealand Journal of Psychiatry, 38, 10-19.  
  
 
 
 
 
 
  
 
 
 
